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Coliform mastitis has been a primary focus of dairy cattle disease research due to 
staggering affiliated losses, severe systemic complications arising from host 
inflammatory response to lipopolysaccharide, and the poor response of coliform 
pathogens to antimicrobials. Reliable biomarkers are needed to evaluate the efficacy 
of adjunctive therapies for the treatment of inflammation associated with coliform 
mastitis, and to aid in the approval of new veterinary drugs. The aims of the current 
analyses were to utilize proteomic methodologies to evaluate protein expression in 
whey from cows with experimentally induced coliform mastitis, and to employ label-
free quantification strategies to estimate changes in relative abundance of proteins 
  
identified in milk over the course of clinical infection.  Two-dimensional gel 
electrophoresis followed by matrix-assisted laser desorption/ionization time-of-flight 
(MALDI- TOF) mass spectrometry (MS) resulted in the identification of complement 
factors, antimicrobial proteins, and acute phase proteins in mastitic milk. Analysis 
using liquid chromatography (LC) inline with electrospray ionization - quadrupole 
TOF tandem mass spectrometry (MS/MS) resulted primarily in the identification of 
abundant whey and casein proteins, and the transient detection of proteins related to 
host response. Nano-LC- nanospray-MS/MS using a linear ion trap, however, led to 
the robust discovery of over fifty inflammatory proteins in whey from mastitic milk, 
including the novel markers kininogen-2 and inter-alpha trypsin inhibitor heavy 
chain-4.  Normalized spectral counts were compared to enzyme-linked 
immunosorbant assay (ELISA) for select proteins to assess the accuracy of the 
spectral count data. Similar expression patterns were detected using spectral counts 
and ELISA. Results indicate that proteomic methodologies can detect biomarkers of 
coliform mastitis in bovine milk during clinical infections, and that spectral counts 
are a viable means of evaluating relative changes in protein biomarkers of mastitis, 
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The research detailed in the following dissertation is part of an on-going joint effort 
between two offices within the U.S Food and Drug Administration’s Center for 
Veterinary Medicine (CVM), the Office of Research (OR), and the Office of New 
Animal Drug Evaluation (ONADE).   The primary goal of this research collaborative 
is to identify reliable biomarkers of inflammation associated with disease in food 
producing animals for the purpose of establishing industry guidance for the 
evaluation of the efficacy of new animal drugs that have claims to treat inflammation.  
As a part of the continued efforts to identify biomarkers of food animal disease, the 
following dissertation describes preliminary investigations designed primarily for the 
purposes of method development and discovery, which were conducted in 
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Chapter 1: Introduction 
Mastitis, or intramammary inflammation, is a disease of primary significance in 
agricultural research due to staggering direct and affiliated economic losses, the 
inability of the host to eradicate causative pathogens, and the absence of efficacious 
treatment options when certain bacterial strains are the causative agent (DeGraves 
and Fetrow, 1993; Seegers et al., 2003). Manifestations of mastitis include decreased 
milk production, compositional changes in the milk, abnormal milk appearance, 
swelling and pain in the udder, elevated rectal temperature, depression, and decreased 
feed intake (Harmon, 1994). The host immune response elicited by the invading 
bacteria is variable, however, and can fluctuate in severity depending on the bacterial 
strain (Bannerman et al., 2004; Petzl et al., 2008).  
Mastitis that results from the invasion of gram-negative environmental bacteria is 
of particular concern to producers and practitioners, due primarily to the presence of 
lipopolysaccharide (LPS), a toxin that is shed from the outer wall of gram negative 
pathogens and that induces a rapid inflammatory response in the bovine mammary 
gland (Paape et al., 1996; Lee et al., 2003).  The profound inflammation and affiliated 
deleterious secondary effects caused by LPS are difficult to alleviate, and to date no 
entirely efficacious treatments exist. Antibiotics are not effective in treating coliform 
mastitis (Hogan et al., 1989; Wilson et al., 1999; Erskine et al., 2000), and while 
vaccines against coliforms are commercially available, immunization with the 
vaccines based on E. coli J5 bacterins only appeared to augment bacterial clearance 
rates in infected glands (Hogan et al., 1992; Tomita et al., 2000; Wilson et al., 2007). 




mastitis is the use of non-steroidal anti-inflammatory drugs or NSAIDs (Anderson, 
1989; Lohuis et al., 1991; Vangroenweghe et al., 2005), but due to the lack of valid 
criteria to evaluate efficacy, only the nonselective NSAID Banamine® has been 
approved for use in lactating dairy cattle. 
Because few viable treatment options are available, a tremendous amount of 
research has been dedicated to elucidating the mechanisms and mediators involved in 
the host response of the bovine mammary gland to infection with gram- negative 
pathogens.  Because of the prevalence of Escherichia coli in the environment of dairy 
cattle, and the frequency of coliform mastitis, E. coli has been used experimentally to 
induce mastitis (Hirvonen et al., 1999; Riollet et al., 2000; Bannerman et al., 2004). 
Several inflammatory mediators have been reported to increase significantly 
following experimental induction of coliform mastitis with E. coli including: the 
cytokines tumor necrosis factor-alpha (TNFα), interleukin-1 beta (IL-1β), interleukin-
8 (IL-8), and interleukin-6 (IL-6; Bannerman et al., 2004); several acute phase 
proteins including serum amyloid A (SAA), haptoglobin (Hp), and alpha-1-acid-
glycoprotein (A1AG; Hoeben et al., 2000; Ekersall et al., 2001; Ceciliani et al., 
2005); and complement factor 5a (C5a), the pro-inflammatory byproduct of 
complement activation (Shuster et al., 1997; Rainard and Poutrel, 2000).  
Additionally, knowledge of the role of toll-like receptors (TLR) and affiliated 
signaling pathways activated during the bovine innate immune response following 
infection with gram-negative pathogens has expanded in recent years (De Schepper et 




The desire to elucidate targets for novel drug therapies for coliform mastitis, coupled 
with the need to identify biomarkers to evaluate the efficacy of new and existing drug 
therapies, has provided a stimulus for investigations into the bovine milk proteome.  
Despite hindrances related to biological complexity, numerous post-translational 
modifications (PTMs), and the dynamic range of proteins in milk (O’Donnell et al., 
2004), attempts have been made to study the dynamics of differential protein 
expression during bovine mastitis (Hogarth et al., 2004; Smolenski et al., 2007). 
Although significant limitations prevent the full characterization of the bovine milk 
proteome (O’Donnell et al., 2004; Garbis et al., 2005; Lippolis and Reinhardt, 2008), 
advances have been made in identifying low abundance proteins in normal bovine 
whey (Fong et al., 2008), the milk fat globular membrane (MFGM; Reinhardt and 
Lippolis, 2006; 2008; Fong et al., 2007), and in various other bovine milk fractions 
(Yamada et al., 2002; Smolenski et al., 2007).  The proteomic analyses of mastitic 
bovine milk performed thus far, however, have been on milk samples collected from 
cows with mastitis that was established based on clinical parameters (Hogarth et al., 
2004), or the analysis was conducted on samples from only one cow with a naturally 
occurring clinical infection (Smolenski et al., 2007).  Additionally, neither of the 
previous analyses of differential protein expression in bovine milk during mastitis 
involved samples collected over the course of a clinical infection (Hogarth et al., 
2004; Smolenski et al., 2007).  Nonetheless, the use of proteomic methodologies to 
evaluate protein changes in milk during the inflammatory response associated with 
coliform mastitis, coupled with existing knowledge of soluble mediators of 




biomarkers, indicative of the disease. In order to be considered robust, biomarkers of 
coliform mastitis must exhibit consistent expression patterns across a group of cows 
at more than one time point following infection.  Likewise, a reliable means of 
quantifying the relative abundance of differentially expressed bovine milk proteins 
over the course of clinical mastitis must be established, especially if no bovine-
specific antibodies are available for the protein(s) of interest.  If the difficulties 
inherent to the characterization of the bovine milk proteome could be overcome, and 
the criteria for accuracy, sensitivity, and specificity met, biomarkers of mastitis could 
prove useful in evaluating the efficacy of existing or new drugs to treat secondary 
inflammation caused by gram-negative pathogens, or for the discovery of potential 





Chapter 2: Literature Review 
 
Bovine Mastitis 
Mastitis, or inflammation of the mammary gland as a result of invasion of 
bacterial pathogens or injury to the gland, has been both a primary concern for dairy 
producers, as well as a main focus of dairy cattle disease research for over a century.  
Of the causes of mastitis, bacteria are by far the most common.  Bacteria gain access 
to the mammary gland via the teat canal, and cause infections that may decrease milk 
production, change the composition and appearance of milk, cause swelling and pain 
in the udder, elevate rectal temperature, and decrease feed intake (Harmon, 1994). 
Mastitis can vary in severity, and is classified as subclinical, clinical, or chronic 
(Eberhart et al., 1987; Harmon, 1994).  Subclinical infections are usually only 
manifest by increases in bulk tank somatic cell counts (SCC) and decreased 
production (Eberhart et al., 1987), whereas clinical infections are marked by changes 
in the milk, such as clots or flakes, that can be detected during fore-stripping prior to 
milking, or by the appearance of the udder, which can become swollen and hot to the 
touch (Harmon, 1994). The economic losses attributed to mastitis are staggering, and 
result from decreased milk yields, discarded milk due to treatment with antibiotics, 
loss of quality premiums, reduced longevity of animals, lowered salvage value of 
culled cows, elevated labor costs, higher veterinary and treatment bills, and increased 
cost of replacing animals in the lactating herd (Eberhart et al., 1987; DeGraves and 




Bacteria that cause mastitis are classified as either contagious or environmental 
pathogens. The most common contagious mastitis pathogens are Streptococcus 
agalactiae and Staphylococcus aureus, gram positive bacteria that usually cause 
decreased milk production, clinical mastitis, and elevated somatic cell counts in some 
cases (SCC; Eberhart et al., 1987; Schroeder, 1997). Contagious organisms are well 
adapted to grow and survive in the mammary gland, and frequently cause infections 
lasting weeks, months or years. The major reservoir for contagious pathogens is the 
infected udder. Contagious pathogens can spread easily from cow to cow during 
milking time as the result of improper sanitation of milking units, by the recycling of 
dairy towels used on infected cows, or the contaminated hands of milking personnel 
(Harmon, 1994).    Most species of gram positive bacteria, excepting S. aureus, are 
effectively eliminated by treatment with antibiotics. S. aureus can be more 
problematic to clear, however, and is often associated with subclinical chronic 
inflammation characterized by periodic flare-ups of clinical symptoms, and often 
recurs in subsequent lactations (Schroeder, 1997).   
Environmental pathogens, on the other hand, are most prevalent in the cow’s 
environment including bedding, soil, and manure, and are often isolated from acute 
cases of clinical mastitis (Zehner et al., 1986; Schroeder, 1997; Hogan et al., 1999). 
Environmental mastitis pathogens are typically gram-negative bacteria, and include 
the coliforms Escherichia coli, Klebsiella pneumoniae, Enterobacter spp., and 
Serratia marcescens (Schroeder, 1997). Gram-negative bacteria are characterized by 
the presence of lipopolysaccharide (LPS) in their outer membrane, a compound 




(Paape et al., 1996; Lee et al., 2003). LPS causes the secondary clinical signs 
associated with coliform mastitis including high fever, depressed appetite, rapid 
weight loss, abnormal milk, and decreased milk production (Baumann and Gauldie, 
1994; Hirvonen et al., 1999; Hoeben et al., 2000). Severe cases of coliform mastitis 
can also result in bacteremia and septicemia, as the blood-milk barrier is destroyed 
and LPS leaks into circulation (Wenz et al., 2001). The ensuing acute systemic 
symptoms of coliform mastitis may include respiratory distress, metabolic 
imbalances, tissue injury, and death (Lohuis et al., 1990; Wenz et al., 2001). 
Mastitis infections caused by gram-negative pathogens are problematic to treat, 
mainly because the deleterious effects of the endotoxin released by gram negative 
bacteria are not ameliorated by antimicrobials.  In fact, several studies have 
demonstrated that antibiotics have little or no efficacy in treating clinical or 
subclinical cases of coliform mastitis (Hogan et al., 1989; Erskine et al., 2000).  Herd 
management practices that are effective in controlling and reducing incidence of 
mastitis caused by gram- positive bacteria, such as post-milking teat dips and dry cow 
antibiotic therapies, have likewise proven to be ineffective in the control of coliform 
mastitis due mainly to the prevalence of coliforms in the environment of the cow 
(Smith et al., 1985).   
The core and lipid A regions of LPS in the cell wall of coliforms are conserved 
across many of the pathogens and have, as a result, been targeted as viable antigens 
for vaccine development (Tyler et al., 1991; 1992).   Challenge studies have revealed, 
however, that immunization with the commercially available vaccines based on E. 




clearance rates in infected quarters, but did not minimize the severity of coliform 
mastitis or prevent development of the disease (Hogan et al., 1992; Tomita et al., 
2000; Wilson et al., 2007).  
To date, the only treatment that has shown promise as an adjunctive therapy for 
coliform mastitis is the use of non-steroidal anti-inflammatory drugs or NSAIDs 
(Anderson, 1989; Lohuis et al., 1991; Vangroenweghe et al., 2005).  Nonsteroidal 
anti-inflammatory drugs function by inhibiting cyclooygenase (COX), the enzyme 
responsible for the oxidation and subsequent conversion of arachidonic acid to 
prostaglandins, a class of compounds that are well known mediators of pain and 
inflammation (Soberman and Christmas, 2003). Two forms of COX have been 
identified, the constitutively expressed COX-1 that is associated with the production 
of cytoprotective prostacyclin in the gastric mucosa (Whittle et al., 1980), and COX-
2, the inducible form that is involved in inflammation (Xie et al., 1992).  COX-2 is 
only expressed following induction by inflammatory stimuli such as cytokines and 
intracellular messengers; thus, COX-2 has been the focus of several studies regarding 
the anti-inflammatory action of NSAIDs (Vane and Botting, 1998). Currently the 
efficacy of NSAIDS in treating inflammation associated with coliform mastitis is 
evaluated by the ability to cause a 2 degree drop in rectal temperature, and a decrease 
in serum concentration of prostaglandin E2 (PGE2; ONADE, personal 
communication).  Reliance on measuring a reduction in PGE2 concentration as an 
indicator of NSAID efficacy is problematic, however, due to the fact that PGE2 can 
vary significantly between animals, and the compound is known to metabolize rapidly 




efficacy, only the nonselective NSAID Banamine® has been approved for use in 
lactating dairy cattle.  
The economic impact of mastitis, coupled with the need to develop novel 
adjunctive therapies, has inspired decades of research on the subject of coliform 
mastitis with topics as varied as: the effects of nutrition on immune function (Smith et 
al., 1984; Chew, 1987);  the relationship between quantitative measures of productive 
life, udder health, and incidence of mastitis (Coffey et al., 1986; Shook and Schultz, 
1994; Cranford and Pearson, 2001); induction of cytokines and soluble inflammatory 
mediators during coliform infections, (reviewed in Bannerman, 2009); and the role of 
the Toll-like receptors (TLR) in the bovine innate immune response (De Schepper et 
al., 2008; Ibeagha-Awemu et al., 2008; Yang et al., 2008).  Following advances in 
techniques for protein and peptide analysis, studies regarding host response during 
coliform mastitis have likewise gravitated towards the identification of differentially 
expressed proteins in bovine milk during mastitis infections, and annotation of the 
bovine milk proteome (Hogarth et al., 2004; Smolenski et al., 2007; Fong et al., 2007; 
2008; Reinhardt and Lippolis, 2006; 2008). 
Studies of the bovine innate immune response during coliform mastitis have 
established that LPS, via association with LPS-binding protein (LBP), cluster of 
differentiation-14 (CD-14), and various other scaffold proteins such as MyD88, binds 
to Toll-like receptor-4 (TLR4), and induces an inflammatory response through the 
activation of nuclear factor kappa-B (NF-kB), a cytoplasmic factor that controls 
transcription of many genes, including proinflammatory cytokines (Pahl, 1999; 




investigated (Notebaert et al., 2008). Intramammary concentrations of NF-kB were 
shown to increase in vivo in murine mammary glands following inoculation with E. 
coli, with corresponding activation in hepatic tissue, and increases in systemic 
circulation levels of both cytokines and acute phase proteins (Notebaert et al., 2008). 
 Cytokines known to be upregulated following infection with gram negative 
bacteria include: tumor necrosis factor-alpha (TNFα), interleukin-1 (IL-1), interferon-
gamma (IFN-γ), interleukin-6 (IL-6), interleukin-8 (IL-8), interleukin-10 (IL-10), 
interleukin-12 (IL-12), transforming growth factor-alpha (TGF-α), and transforming 
growth factor-beta (TGF-β; reviewed in Bannerman, 2009). In particular, studies have 
demonstrated that the acute symptoms of coliform mastitis are closely related to milk 
and serum levels of the cytokines TNFα, IL-1β, and IL-8 (Sordillio and Peel, 1992; 
Riollet et al., 2000).   IL-1β is a potent inducer of fever (Dinarello, 1998), as well as 
the acute phase response, and is produced by a variety of cell types (reviewed in 
Bannerman, 2009). IL-1β and TNFα act redundantly in the activation of leukocytes 
and endothelial cells, and both can elicit very harmful secondary effects including 
altered vascular permeability, shock, and tissue injury (Bannerman, 2009).  TNFα and 
IL-1β also upregulate the expression of vascular adhesion molecules such as E-
selectin, which promotes the adhesion of leukocytes to vascular walls, and ultimately 
results in passage of leukocytes through blood vessel walls (Beutler, 2004). During 
intra-mammary infections, both TNFα and IL-1β have been reported to exhibit 
increased concentrations in milk by 18 h following experimental induction of mastitis 




 IL-8 is a chemokine that stimulates the migration of neutrophils into the 
mammary gland from circulation during intramammary infection (Beutler, 2004; 
Bannerman, 2009). In addition to attracting neutrophils to the site of inflammation, 
IL-8 has also been shown to directly augment neutrophil phagocytosis, priming, 
degranulation, and oxygen radical production (Watson et al., 1995; McClenahan et 
al., 2000). Increases in IL-8 have been detected in milk within 16 h following 
experimental challenge with E. coli (Lee et al., 2003 Bannerman et al., 2004).  
Similarly, recent studies have indicated that platelet activating factor (PAF) is 
produced by mammary endothelial cells in response to challenge with LPS, and that 
in addition to IL-8 and IL-1β, PAF likewise serves as a chemotactic factor to recruit 
leukocytes to the gland during mastitis (Corl et al., 2008). 
The actions of IL-6, another prominent cytokine involved in the bovine innate 
immune response, include fever induction, B-cell differentiation, T-cell activation, 
and the inhibition of TNFα and IL-1β (reviewed in Bannerman, 2009). A more 
prominent function of IL-6 during inflammation, however, is the stimulation of the 
hepatic production of acute phase proteins (APP) including serum amyloid A (SAA), 
haptoglobin (Hp), and α-1-acid glycoprotein (A1AG; reviewed in Heinrich et al., 
1990). Similar to IL-8, milk concentrations of IL-6 have been observed within 16 h 
following experimental induction of coliform mastitis with E. coli (Shuster et al., 
1997). 
In contrast to data available on the expression and actions of cytokines during 
coliform mastitis, less is currently known regarding the roles of APP during 




mammary gland following challenge with either LPS or E. coli have reported 
increases in the APP SAA, Hp, A1AG, and LBP in milk during clinical mastitis 
(Hirvonen et al., 1999; Eckersall et al., 2001; Bannerman et al., 2003; Hiss et al., 
2004; Ceciliani et al., 2005).  While the primary source of APP is the liver, local 
production of SAA, Hp, and A1AG in the bovine mammary gland have been 
demonstrated (Hiss et al., 2004; Jacobsen et al., 2005; Ceciliani et al., 2005; Larson et 
al., 2006). In addition to local and hepatic production, the granules of bovine 
neutrophils are likewise a reported source of A1AG (Rahman et al., 2008). A recent 
analysis of the temporal expression of SAA, Hp, and LBP during experimentally 
induced E. coli mastitis indicated that increases in all three major APP began as early 
as 12 h following infection, but unlike peak expression of the major cytokines 
involved in inflammation during coliform mastitis, maximum levels of the APP were 
not detected in milk until 36-60 h after challenge (Suojala et al., 2008).  
Until the past decade, the discovery of biomarkers specific to the host response 
during gram-negative intramammary infection has been limited to the study of the 
expression of cytokines and other soluble mediators of inflammation during clinical 
mastitis, and information has been derived primarily from enzyme-linked 
immunosorbent assays (ELISA).  The chief limitation of utilizing methodologies such 
as ELISAs in biomarker discovery analyses, however, is that ELISAs are designed to 
measure only one protein at a time, and are limited by antibody development and 
availability.  Recent advances in both genomic and proteomic strategies have given 
rise to novel assessments of the bovine innate immune response following E. coli 




of a DNA-microarray to profile changes in the transcriptome of mammary epithelial 
cells (MEC) after gram-negative bacterial infection (Gunther et al., 2009), and the 
proteomic analysis of bovine milk fractions using liquid chromatography followed by 
tandem mass spectrometry (LC-MS/MS) to identify proteins related to host response 
in milk during clinical mastitis (Smolenski et al., 2007).  DNA microarray of MEC 
following challenge with E. coli revealed upregulation of genes encoding 
chemokines, interleukins, beta-defensins, SAA, and Hp, results which are all in 
accord with previous analyses (Eckersall et al., 2001; Bannerman et al., 2004; 
Gunther et al., 2009). Proteomic analyses of mastitic bovine milk, on the other hand, 
led to the identification primarily of antimicrobial and antigen recognition proteins 
(Smolenski et al., 2007). While no strategy is without limitations, the advances in 
mastitis research made in the past decade in regards to elucidation of cytokine 
expression, signaling pathways, and differential gene and protein expression during 
coliform mastitis will prove useful in the discovery and establishment of biomarkers 
of mastitis for use in disease detection and diagnosis, and in the evaluation of novel 
therapeutics. 
Biomarker Discovery 
By definition, a biomarker is “a characteristic that can be measured and 
evaluated as an indicator of normal biological processes, pathological processes or 
pharmacologic responses to therapeutic interventions” (NIH Biomarkers Definitions 
Working Group, 1998).  Several types of biomarkers have been described, including: 
diagnostic biomarkers used to identify the presence or absence of a disease (Taba et 




efficacy of drug therapies to treat disease (Boenisch and Chandraker, 2008; Sakurada 
and Tsao, 2009); and surrogate biomarkers that are regarded as valid substitutes for 
measuring clinical outcomes (Bose et al., 2004).  To be considered a “good” 
biomarker, an indicator of disease must exhibit accuracy, sensitivity, and specificity; 
thus, more simply stated, the expression of a biomarker must be specific to a disease, 
unaffected by unrelated disorders, and reliable and reproducible quantification of the 
biomarker must be possible (LaBaer, 2005; Issaq and Blonder, 2009). 
Proteomics has been defined as a scientific approach used to elucidate all proteins 
within a cell or tissue (Colantonio and Chan, 2005). Over the past decade, proteomic 
methodologies including two dimensional electrophoresis (2D-GE) and mass 
spectrometry (MS), have become the most prominent approaches used to identify 
novel biomarkers (Mann et al., 2001; Issaq and Blonder, 2009).   Genomic 
methodologies, including gene arrays and the evaluation of mRNA expression using 
polymerase chain reaction (PCR), have also been used for biomarker discovery, but 
proteomics boasts a significant advantage over genomic analyses because of the 
demonstrated weak correlation that often exists between mRNA levels and actual 
protein concentration. Thus, quantitative mRNA data is often an inadequate indicator 
of protein expression (Gygi et al., 1999; Ideker et al., 2001; Griffin et al., 2002; Tian 
et al., 2004).  
Chromatography and electrophoresis, when coupled with mass spectrometry, 
are the combined methodologies of choice when considering the identification of 
proteins in complex biological matrices (Mann et al., 2001; Roe and Griffin, 2006; 




including electro-spray ionization (ESI) and matrix-assisted laser 
desorption/ionization (MALDI), have broadened the applications of mass 
spectrometry to include intact protein and peptide analysis, and have paved the way 
for ground-breaking studies into the dynamics of differential protein expression 
(reviewed in Mann et al., 2001).  The basic distinguishing features between MALDI 
and ESI are the reliance of MALDI ionization on a crystallizing energy absorbing 
matrix for ion formation, as opposed to a liquid solvent matrix utilized by ESI, and 
the fact that MALDI ionization routinely results in the production of singly-charged 
ions, whereas ESI produces multiply-charged ions (Karas et al., 1987; Tanaka et al., 
1988; Fenn et al., 1989).  Another distinction between the two forms of soft 
ionization is that the generation of ions in MALDI is initiated by short pulse 
irradiation with a laser (Karas and Krüger, 2003), typically nitrogen or neodymium-
doped yttrium aluminium garnet (Nd:YAG), whereas ESI generates ions via the 
passage of a liquid mixture of solvent and the target analyte through a metal capillary 
tube to which a charge is applied (Fenn et al., 1989). Nanospray is another very 
popular ionization method employed in mass spectrometry-based proteomic analyses 
that is very similar in principle to ESI.  The primary distinctions between ESI and 
nanospray are the significantly lower flow rates and smaller needle diameters used for 
nano- spray (Kinter and Sherman, 2000). 
In MALDI-MS analyses, the analytes, which can include peptides, proteins, 
synthetic polymers, oligonucleotides, oligosaccharides, or drugs and metabolite 
systems (Hillenkamp et al., 1991; Nordhoff et al., 1992), are mixed with an energy 




of matrix molecules and subsequent proton transfer to the thermally labile analyte 
molecules (Hillenkamp et al., 1991; Karas and Krüger, 2003).  Common matrices 
used in MALDI analyses are 3,5-dimethoxy-4-hydroxycinnamic acid (sinapinic acid; 
SPA), α-cyano-4-hydroxycinnamic acid (CHCA) and 2,5-dihydroxybenzoic acid 
(DHB; Beavis and Chait, 1989; Kosaka and Kinoshita, 1996).   
Conversely, the formation of ions in ESI mass spectrometry begins with the 
mixing of the sample to be analyzed with a solution containing a volatile solvent as 
well as volatile acids, bases, or buffers (Fenn et al., 1989; 1990).  The mixture is then 
passed through a highly charged metal capillary at a very low flow rate (Fenn et al., 
1989; 1990). Due to charge repulsion, the solvent:analyte mixture propels itself 
through the capillary and emerges as an aerosol mist consisting of small charged 
droplets about 10 µm across (Fenn et al., 1989; 1990; Nguyen and Fenn, 2007).  
Solvent evaporation leads to the decomposition of the initial droplets into smaller and 
more highly charged offspring droplets, a process that eventually leads to observable 
ions (Kebarle, 2000; Nguyen and Fenn, 2007).  
Mass spectrometers measure the mass-to-charge ratio (m/z) of analytes, 
including proteins and peptides, by mass separation (Mann et al., 2001).  The three 
basic means of achieving mass separation include: 1) separation based on time-of-
flight (TOF MS); 2) separation by quadrupole electric fields generated by metal rods 
and the application of direct current (dc) and radio frequency (rf) (quadrupole MS); 
and 3) separation by selective ejection of ions from a three-dimensional trapping field 
(ion trap/ Fourier transform ion cyclotron MS; Mann et al., 2001).  Peptide 




(MS/MS), which can be done by using the same separation principle twice, or 
utilizing two different MS separation principles (Mann et al., 2001). 
MALDI is a discontinuous ionization technique and is therefore typically 
coupled to a TOF mass analyzer (Mann et al., 2001).  Time-of- flight instruments are 
well suited to MALDI ion sources because MALDI produces brief pulses of ions that 
are followed by relatively long periods of measurement during which no additional 
ions can be allowed into the instrument’s analyzer (Fenyö and Beavis, 2008).   
Structural information can be obtained when peptide ions formed by MALDI decay 
as the result of energy departing during the desorption process, an event referred to as 
post source decay (PSD; Mann et al., 2001). MALDI-TOF instruments are also 
typically used to generate peptide mass fingerprints (PMF) of proteins, or a set of 
peptide masses resulting from enzymatic digestion with a protease such as trypsin 
(Mann et al., 2001). 
ESI is most often combined with quadrupole mass separation wherein the 
quadrupole serves as a mass filter that, following the application of an oscillating 
electric field, only lets ions of a certain mass to pass through (Mann et al., 2001).  
Triple quadrupole mass spectrometers have also been merged with the TOF 
instruments wherein the third quadrupole section is replaced by a TOF analyzer (Q-
TOF; Morris et al., 1996). ESI is likewise used often with ion-trapping instruments 
that utilize three-dimensional electric fields to trap ions, and additional electric fields 
to eject ions one species at a time from the trap (reviewed in Mann et al., 2001).  




accuracy of the trap instruments do not approach those of the Q-TOF instruments 
(Mann et al., 2001). 
Advances in mass spectrometry have provided a means for the accurate and 
sensitive identification of differentially expressed proteins in complex biological 
samples, but another important criterion of quality biomarkers is reliable 
quantification. Relative and absolute quantification of changes in abundance of 
biomarkers in biological matrices using proteomic strategies is a topic that has 
garnered significant attention in recent years (Roe and Griffin, 2006; Fenselau, 2007; 
Mueller et al., 2008; Simpson et al., 2009).  Quantification methods can be assigned 
to one of two broad categories: a labeled approach that requires the incorporation of 
labels into proteins or peptides prior to MS analysis, or the alternative, which is to use 
a semiquantitative label-free method (Simpson et al., 2009).  
The basis of most labeled quantification methods is the stable isotope dilution 
principle, or the theory that a labeled peptide will behave chemically in the same 
fashion as its unlabeled counterpart, and therefore the two peptides will have identical 
chromatographic and MS properties (Simpson et al., 2009).  The addition of a label, 
however, does impart a mass difference between the two peptides, and thus relative 
abundance can be inferred by comparing the respective signal intensities of the 
labeled and unlabeled peptides in the same MS run (Simpson et al., 2009).  Labels 
can be incorporated in several ways, with the most popular being either metabolically, 
chemically, or enzymatically (Fenselau, 2007; Simpson et al., 2009). Examples of 
labeling strategies include: metabolic labeling commonly known as stable isotope 




labeling with 18O (Yao et al., 2003); or isotope incorporation by several means 
including chemical derivatization also known as isotope coded affinity tags or ICAT 
(Gygi et al., 1999), isobaric tags for relative and absolute quantitation (iTRAQ; Ross 
et al., 2004), or global internal standard technology (GIST; Chakraborty and Regnier, 
2002). 
Some labeling strategies can be cost-limiting, however, and thus there has been 
interest in quantification without the incorporation of labels.  Label-free strategies are 
based on the correlation between the abundance of a protein or peptide in a sample, 
and the MS signal (Simpson et al., 2009).  One of the most popular methods of label-
free quantification is extracted ion chromatograms (XIC), in which the number and 
intensity of selected precursor ions at a particular m/z  are summed and the peaks 
areas used as a measure of relative abundance (Old et al., 2005).  An alternative 
approach that is gaining popularity is spectral counting, or the number of MS/MS 
fragment spectra that contribute to the identification of a given protein (Liu et al., 
2004; Zybailov et al., 2005). Similarly, the number of unique peptides identified for 
each protein in a sample has likewise been used as a measure of relative protein 
abundance (Liu et al., 2004).  An inherent drawback of label-free methods, though, is 
the assumption that the linearity of response will be the same for each protein, which 
often does not hold true because the chromatographic behavior of peptides tends to 
vary (Simpson et al., 2009).  Thus, many spectra must be acquired and spectral counts 
or XIC normalized when using label- free methods (Old et al., 2005).  Nevertheless, 
label-free quantification does not require any extra sample processing and can be 




methods the continued focus of development in biomarker discovery research 
(Simpson et al., 2009).     
 
Milk Proteomics 
Milk proteins have been the subject of intense research for over fifty years.  
Despite numerous in-depth analyses however, many questions still remain regarding 
expression of bovine milk proteins, interactions between milk proteins, and the 
structure, function, and modification of milk proteins (O’Donnell et al., 2004). A 
major limitation in studying the bovine milk proteome has been the biological 
complexity of milk, a problem made even more complicated by the numerous post-
translational modifications (PTMs) that occur in milk proteins including 
glycosylation, phosphorylation, disulphide bond formation, and proteolysis 
(O’Donnell et al., 2004).  Additionally, analyses of the bovine milk proteome are 
hampered by the dynamic range of proteins in milk, which are known to vary in 
concentration by as much as a factor of 106 (O’Donnell et al., 2004; Gagnaire et al., 
2009). Despite the somewhat overwhelming abundance of just a few select proteins, 
however, the bovine milk proteome is extremely complex due to the existence of 
numerous low abundance proteins that comprise approximately 5% of the total 
protein concentration of bovine milk (Gagnaire et al., 2009). Since the beginning of 
the 1990s, proteomic methodologies have been applied to the study of milk proteins 
and several advances have been made including the identification of minor or low 
abundance proteins in bovine milk and affiliated subcellular compartments, 




characterization of several PTMs that occur frequently in milk proteins (Gagnaire et 
al., 2009).   
Proteomic analyses typically employ the two-step strategy of protein or peptide 
separation followed by identification of the protein (reviewed in Garbis et al., 2005).  
The most popular approaches to the two-fold process of protein discovery are 2D-GE 
for the separation of proteins followed by identification using MALDI–TOF-MS, and 
one- or two-dimensional liquid chromatography (LC) for protein or peptide 
separation followed by protein identification using ESI and tandem mass 
spectrometry (MS/MS; O’Donnell et al., 2004; Garbis et al., 2005).  Protein discovery 
also entails digestion of isolated intact proteins or mixtures of proteins with an 
enzyme such as trypsin either prior to or following separation by either 2D-GE or LC 
(O’Donnell et al., 2004; Garbis et al., 2005; Gagnaire et al., 2009).   
Proteomic approaches are broadly classified as either a top-down approach, which 
entails separation of intact proteins prior to digestion and identification of the protein 
by either peptide mass mapping or peptide sequencing, or a bottoms-up analysis that 
involves digestion of complex protein mixtures followed by the separation of peptides 
using one- or two-dimensional LC.  Typically, pre-fractionation steps are employed 
in most proteomic analyses to reduce sample complexity and increase proteome 
coverage (Righetti et al., 2005; Gagnaire et al., 2009). Common pre-fractionation 
techniques used in proteomic analyses include: separation of proteins or peptides 
using centrifugation, electrophoresis or chromatography; fractionating based on 
isoeletric point (IEF) or size; and selective depletion of high abundance proteins 




have included the removal of caseins by acid precipitation (Baeker et al., 2002; 
Hogarth et al., 2004; Fong et al., 2008), immunoabsorption (Yamada et al., 2004), or 
by ultra-centrifugation (Smolenski et al., 2007); removal of the milk fat by 
centrifugation at reduced temperatures (Galvani et al., 2001; Baeker et al., 2002; 
Yamada et al., 2002; Hogarth et al., 2004; Smolenski et al., 2007; Fong et al., 2008); 
and the fractionation of whey following removal of the fat and caseins using fast 
protein liquid chromatography (FPLC; Fong et al., 2008). While attempts to reduce 
the complexity of bovine milk and affiliated subcellular fractions have resulted in 
more thorough comprehension of the complete bovine milk proteome, a tremendous 
gap in knowledge still exists regarding bovine milk protein modulation during disease 
(O’Donnell et al., 2004). 
Proteomic strategies were first applied to the study of the bovine milk proteome in 
the late 1980s, and were predominantly focused on analysis and characterization of 
the most abundant milk proteins (O’Donnell et al., 2004; Gagnaire et al., 2009). The 
early forays utilized either 2D-GE or LC alone, and were performed only on bovine 
whole milk (Shimazaki et al., 1983; Holt and Zeece, 1988; Bobe et al., 1998).  The 
preliminary attempts to analyze bovine milk proteins were successful only in 
separating the major whey proteins serum albumin, β-lactoglobulin, and α-
lactalbumin, and the caseins αS-casein and β-casein (Shimazaki et al., 1983; Holt and 
Zeece, 1988).  Additionally, protein identification was based solely on a previous 
report of the isolelectric points and molecular weights of bovine milk proteins 
(Whitney et al., 1977).  Sample preparation methods in the early milk proteome 




analysis, and were comprised of either acid precipitation followed by centrifugation 
(Shimazaki et al., 1983), or centrifugation alone (Holt and Zeece, 1988).   
The earliest attempt to identify bovine milk proteins via LC coupled with MS 
(LC-MS; Léonil et al., 1995) were limited to the detection of only the major milk 
proteins β-lactoglobulin, α-lactalbumin, α-casein, β-casein, and κ-casein, and lacked 
peptide sequencing data to support the authors’ identification of milk proteins on the 
basis of molecular mass.  Pre-fractionation methods utilized by Léonil and colleagues 
involved separating the casein and whey proteins by acid precipitation of the caseins, 
followed by dialysis of both protein fractions (Léonil et al., 1995).    
One of the first studies to employ MALDI to analyze bovine milk proteins 
generated mass spectra on the purified milk proteins β-lactoglobulin, α-lactalbumin, 
α-caseins, β-casein, and κ-casein, and then compared these spectra to a MALDI mass 
spectrum generated from the protein extract of a bulk milk sample (Catinella et al., 
1996).  In the bulk milk sample, the intact proteins β-lactoglobulin, α-lactalbumin, 
proteose peptones, β-casein, and γ-casein were identified.  Sample preparation was 
limited and did not involve attempts to remove high abundance proteins prior to 
analysis (Catinella et al., 1996).  In the same study, MALDI mass spectra of milk 
from several different breeds of dairy cattle including Holstein, Brown Swiss, Jersey, 
and Reggiana cows were likewise examined for differences in protein content and 
abundance (Catinella et al., 1996). Results indicated that the protein content of milk 
collected from Jersey cattle was markedly different from other dairy breeds.  
Likewise, Catinella et al., were able to demonstrate via the comparison of MALDI 




the course of a lactation cycle that compositional differences existed at different 
stages of lactation.  
The first analyses of bovine milk to combine the use of 2D-GE and MALDI-TOF-
MS were analyses conducted on both powdered milk and commercially available 
milk that primarily focused on the identification of the casein and whey proteins, and 
variants of the major milk proteins (Galvani et al 2000; 2001).  Using MALDI-TOF-
MS to identify intact proteins in commercial whole milk, Galvani and colleagues 
were able to identify the whey proteins β-lactoglobulin, and α-lactalbumin, and the 
caseins γ3-casein A2 and γ2-casein A2, both fragments of β-casein A2, as well as αS1-
casein, αS2-casein, β-casein, and κ-casein.  2D-GE profiles were also generated using 
the whole milk samples, but no additional milk proteins were identified (Galvani et 
al, 2001). 
One of the first attempts to identify bovine milk proteins, other than the abundant 
whey and casein proteins, compared bovine colostrum and mature milk collected 
from healthy Holstein cows using 2D-GE, N-terminal sequencing, MALDI-TOF-MS, 
and ESI-MS/MS (Yamada et al., 2002).  In order to identify lower abundance milk 
proteins, the major proteins β-casein and immunoglobulin G (IgG) were removed 
from the milk and colostrum samples using immunoabsorption.  N-terminal 
sequencing of protein spots separated on a 2-DE gel identified αS1-casein, β-casein 
fragments, and β-lactoglobulin and α-lactalbumin (Yamada et al., 2002).  MALDI 
peptide mass fingerprinting (PMF) following in-gel trypsin digestion of proteins 
isolated using 2D-GE allowed for the identification of lactoferrin, serotransferrin, β-




tandem mass spectrometry of tryptic peptides added fibrinogen β-chain, chitinase 3-
like 1, IgM heavy chain, α1-antritrypsin, complement C3 α-chain, and gelsolin to the 
list of identified proteins (Yamada et al., 2002).   
The first demonstrated success of utilizing proteomic techniques to identify novel 
markers for bovine mastitis was the work of Baeker and colleagues, who were the 
first to attempt to characterize differentially expressed proteins in normal and mastitic 
milk using 2D-GE followed by MALDI-TOF-MS.  The presence of lipocalin-type 
prostaglandin D synthase was observed only in the 2D gels generated from samples 
taken from cows with clinical mastitis, and did not appear on gels generated from 
control samples (Baeker et al., 2002).  While Baeker and colleagues were only 
successful in identifying a single differentially expressed protein in mastitic bovine 
milk, the results nonetheless marked the first instance of published literature on a 
marker of inflammation in bovine milk identified using proteomic strategies.  
Following the work of Baeker et al., more focused attempts to identify 
differentially expressed proteins in whey from healthy cows versus cows with clinical 
mastitis were initiated by Hogarth et al., in 2004. Changes in protein composition of 
milk during clinical mastitis were examined using 2D-GE followed by enzymatic 
digestion of isolated proteins and PMF using MALDI-TOF-MS.  The samples were 
collected from cows residing on a commercial dairy, and mastitis was defined strictly 
by identification of clinical signs and not by bacterial culturing or experimental 
induction (Hogarth et al., 2004).  Milk sample preparation prior to analysis included 
fat removal and precipitation of the casein proteins by the addition of salt followed by 




attempts to remove the casein fraction from the milk prior to proteomic analysis, αS1-
casein, β-casein, and κ-casein were still found in rather high abundance in normal 
milk.  Also identified were the proteins serum albumin, transferrin, microsomal 
triglyceride protein, β-lactoglobulin and α-lactalbumin (Hogarth et al., 2004).  
Marked increases in serum albumin and transferrin, concurrent with apparent 
decreases in the casein proteins as well as in β-lactoglobulin and α-lactalbumin, were 
apparent in the 2D-GE profiles generated from whey samples from cows with 
mastitis, and supported the well established theory that serum protein concentration 
increased in milk during mastitis as a result of the breakdown of the blood milk 
barrier during mastitis infections (Hogarth et al., 2004).  While no additional 
information was gained, Hogarth et al., were the first to demonstrate temporal 
changes in bovine milk protein expression during mastitis, though the analysis was 
limited to only normal and mastitic samples, and confirmation of mastitis was based 
only on clinical observations and not experimental induction of the disease. 
Knowledge of more extensive protein changes in bovine milk during a naturally-
occurring mastitis infection was reported by a research group in New Zealand three 
years after the work of Hogarth and colleagues.  The endeavors of Smolenski et al., in 
2007 resulted in the first report of extensive examinations of protein expression in 
separate subcellular fractions of bovine milk during different physiological states 
(Smolenski et al., 2007).  The proteomic techniques employed included direct LC-
MS/MS, as well as 2D-GE followed by MALDI-TOF-MS or MS/MS (Smolenski et 
al., 2007). The milk fractions analyzed included milk from peak lactation, colostrum, 




cow that was recently fresh, one cow that was in mid-lactation, and one cow that was 
suspected to have mastitis based on clinical indications of the disease, the results of 
the analyses conducted by Smolenski et al., were the most comprehensive to date in 
terms of number of low abundance proteins indentified and the number of host 
response proteins that were isolated from mastitic milk (Smolenski et al., 2007).  An 
additional novel aspect to the proteomic analyses conducted by Smolenski and 
colleagues was the fact that no sample clean-up or attempts to fractionate the milk 
were carried out on the samples prior to analysis. Smolenski et al., were the first to 
identify proteins such as apolipoprotein A-1, cathelicidin-1, fatty acid binding protein 
(FABP), glycosylation-dependent call adhesion molecule 1 (Glycam-1), H3 histone, 
heat shock protein 70, nucleobindin, peptidoglycan recognition protein (PGRP), and 
SAA in milk fractions collected from a cow with clinical mastitis (Smolenski et al., 
2007).   
Not all endeavors to characterize low abundance proteins in bovine milk have 
focused on proteins differentially expressed during disease states.  Significant efforts 
have also been made to fractionate whey derived from the milk of healthy cows in 
attempt to identify low abundance proteins.  Fong and colleagues sought to 
characterize proteins other than the abundant caseins and whey proteins in normal 
whey by first removing the milk fat and caseins by centrifugation at 4ºC and acid 
precipitation, respectively. The remaining intact whey proteins were then separated 
using fast protein liquid chromatography (FPLC; Fong et al., 2008). The major whey 
proteins β-lactoglobulin and α-lactalbumin were isolated using semi-coupled anion 




and acidic whey fractions resulting from the FPLC were analyzed using 2D-GE (Fong 
et al., 2008).  Proteins visualized on the 2D gels generated by Fong and colleagues 
were excised, digested with trypsin, and identified using nano-reversed phase- LC 
followed by ESI-MS/MS.  Despite the removal of high abundance casein proteins and 
the elaborate fractionation strategies employed to sequester high abundance whey 
proteins, all of the casein proteins as well as β-lactoglobulin and α-lactalbumin were 
still identified in spots cut from the series of 2D gels (Fong et al., 2008). Additionally, 
the complete fractionation of the abundant milk proteins was not entirely achieved as 
caseins and the whey proteins β-lactoglobulin and α-lactalbumin appeared in gels 
generated from different fractions obtained using FPLC. A significant number of 
previously unidentified whey proteins were detected in the 2D gels generated on the 
whey fractions however, including butyrophilin, alpha-1B-glycoprotein, alpha-2-HS-
glycoprotein, kininogen-1, vitamin D binding protein, antithrombin III, several 
immunoglobulins, complement components C3, C4, C7, and C9, polymeric 
immunoglobulin receptor (PIGR), hemopexin, and lactoperoxidase (Fong et al., 
2008).   
In addition to the characterization of the whey fraction of bovine milk, there have 
been several proteomic analyses of the bovine milk fat globular membrane (MFGM; 
Reinhardt and Lippolis, 2006; 2008; Fong et al., 2007).  In initial proteomic studies of 
the MFGM, Reinhardt and Lippolis utilized 1-dimensional gel electrophoresis (1D-
GE) to fractionate proteins followed by in-gel digestion of protein slices and 
identification of tryptic peptides via MS/MS.  A total of 120 proteins that comprise 




trafficking, cell signaling, fat transport, and immune function (Reinhardt and 
Lippolis, 2006).  The identification of CD9, CD14, immunoglobulin M (IgM), TLR2, 
and TLR4 in the bovine MFGM were novel findings, and confirmed the already 
suspected role of the bovine mammary gland in surveillance and disease detection 
(Reinhardt and Lippolis, 2006).  Follow-up proteomic analyses of the bovine MFGM 
identified fewer proteins, but determined that lipid composition of the MFGM 
consisted primarily of triglycerides and phospholipids (Fong et al., 2007).    
Significant strides have been made in the characterization of proteins that 
comprise the bovine milk proteome since the initial studies that focused primarily on 
describing the abundant milk proteins and their affiliated genetic variants (Shimazaki 
et al., 1983; Holt and Zeece, 1988). Following advances in mass spectrometry, 
including the development and application of soft ionization techniques to the study 
of proteins and peptides, proteomic studies of the bovine milk proteome have led to 
the characterization of low abundance proteins in normal and mastitic whey, as well 
as in colostrum and the MFGM (Reinhardt and Lippolis, 2006; Smolenski et al., 
2007; Fong et al., 2008).  Successful application of proteomic methodologies to the 
identification of differentially expressed proteins in milk collected from cows with 
clinical mastitis has likewise been demonstrated (Hogarth et al., 2004; Smolenski et 
al., 2007). Nonetheless, challenges arising from the biological complexity of milk and 
dynamic range of proteins present in bovine milk remain a hurdle in the 
characterization of the complete bovine milk proteome (O’Donnell et al., 2004; 
Gagnaire et al., 2009).  Additionally, while proteomic techniques have contributed 




milk proteins, a gap still exists between the identification of proteins and the 
quantification of differentially expressed bovine milk proteins manifest during 
disease and at varying stages in lactation (Gagnaire et al., 2009).    Results thus far 
indicate the utility of proteomics in prospective biomarker discovery, and in the 
identification of potential novel drug targets.  However, subsequent research 
endeavors must strive to address apparent inefficiencies in reducing the biological 
complexity of milk in order to accurately target low abundance markers in bovine 
milk, and to bridge the current distance between qualitative and quantitative 





Chapter 3: Objectives 
The Objectives of the following series of analyses were: 
Objective 1 
To generate proteomic profiles of normal bovine whey and whey following 
experimental induction of Escherichia coli mastitis using 2D gel 
electrophoresis, and to identify differentially expressed proteins by matrix-
assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass 
spectrometry with post source decay (PSD).   
Objective 2 
To develop more high-throughput methods of detecting differentially 
expressed bovine milk proteins in whey from normal versus mastitic milk 
using in-solution digestion methods, followed by liquid chromatography 
coupled with tandem mass spectrometry (LC-MS/MS) using both an LC-ESI-




To compare mass spectrometry-based label-free semiquantitiative methods 
including spectral counts and number of unique peptides identified, with 
temporal expression patterns determined using enzyme-linked immunosorbant 




differentially expressed protein biomarkers in bovine milk over a time course 







Chapter 4: Proteomic Analysis of Differentially Expressed 
Proteins in Bovine Milk during Experimentally Induced 
Escherichia coli Mastitis. 
 
Abstract 
The objectives of the current study were to profile changes in protein composition 
using 2-dimensional gel electrophoresis (2D-GE) on whey samples from a group of 8 
cows prior to and 18 hours after infection with Escherichia coli, and to identify 
differentially expressed milk proteins by peptide sequencing using matrix-assisted 
laser desorption/ ionization time-of-flight (MALDI-TOF/TOF) mass spectrometry 
post source decay (PSD).  Only proteins present in whey fractions of all 8 cows were 
sequenced to avoid reporting a protein response unique to only a subset of infected 
cows. Despite the overwhelming presence of casein and β-lactoglobulin, the low 
abundance proteins transthyretin, lactadherin, β-2-microglobulin precursor, α-1 acid 
glycoprotein and complement C3 precursor could be identified in whey samples from 
healthy cows. Whey samples at 18 hours post infection were characterized by an 
abundance of serum albumin, in spots of varying mass and isoelectric point, as well 
as increased transthyretin and complement C3 precursor levels. Also detected at 18 
hours post inoculation were the antimicrobial peptides cathelicidin, indolicidin, and 
bactenicin 5 and 7, and the proteins β-fibrinogen, α-2-HS-glycoprotein, S100-A12, 




acid glycoprotein (A1AG) in mastitic whey samples, a result not previously reported.  
In contrast to methods used in previous proteomic analyses of bovine milk, the 
methods used in the current study enabled the rapid identification of milk proteins 
with minimal sample preparation.  Use of a larger sample size than previous analyses 
also allowed for more robust protein identification.  Results indicate that examination 
of the protein profile of whey samples from cows following inoculation with E. coli 
could provide a rapid survey of milk protein modulation during coliform mastitis and 
aid in the identification of biomarkers of this disease. 





For decades, mastitis has been the most costly disease to impact the dairy 
industry, mainly due to economic losses that stem from decreased milk production, 
reduced milk quality, discarded milk, cow mortality, and increased cull rates 
(Schepers and Dijkhuizen, 1991).   Cases of mastitis arising from infection by gram-
negative bacteria are of particular concern to dairy producers for several reasons: 1) 
coliform pathogens do not respond well to traditional mastitis treatments including 
antimicrobial drugs (Shim et al., 2004); 2) a vaccine developed against coliforms has 
exhibited only limited efficacy (Hogan et al., 1992); and 3) nearly 25% of the cows 
suffering from gram-negative mastitis will either die or be culled as a result of 
systemic complications arising from the host inflammatory response (Eberhart et al., 
1987).  Because there are a limited number of treatment options available, coliform 
mastitis and the innate immune response in the bovine mammary gland have been the 
focus of a considerable amount of research (Hirvonen et al, 1999; Bannerman et al., 
2003; 2004).  Escherichia coli remains the most prevalent gram-negative bacteria 
species to cause bovine mastitis and thus E. coli strains have often been used in 
research to experimentally induce mastitis (Hirvonen et al, 1999; Bannerman et al., 
2004; Lee at al., 2006).   
Dramatic changes in milk protein profiles during coliform mastitis occur in 
response to the release of a toxin from gram-negative bacteria cell walls during 
bacterial replication or death, known as endotoxin or lipopolysaccharide (LPS).  LPS 




mammary gland (Shuster et al., 1993; Lee et al., 2003).  Epithelial cells in the 
mammary gland respond to LPS by producing cytokines including IL-8, TNFα, and 
lactoferrin (Pareek et al., 2005; McClenehan et al., 2005), and it has been established 
that IL-1β, IL-6, IL-8, and TNFα are all upregulated by LPS (Shuster et al., 1993; 
Bannerman et al., 2003).  The cytokines IL-1β, IL-8, and TNFα have also been 
demonstrated to increase in response to E. coli infection in vivo (Bannerman et al., 
2004). IL-1β and TNFα and are established inducers of fever, the hepatic acute phase 
response, and the expression of vascular endothelial adhesion molecules, while the 
chemokine IL-8 is known to play a major role in the recruitment of neutrophils from 
peripheral sites to the mammary gland during mastitis. Cytokine expression following 
exposure to LPS or E. coli is also thought to cause increased permeability of 
mammary vasculature, which subsequently results in a dramatic increase in levels of 
vascular derived proteins in milk, most notably bovine serum albumin (BSA).  
Cytokine expression and the effects of the innate immune response on milk 
composition during coliform mastitis have been previously characterized; however, 
changes in actual expression profiles of milk proteins during coliform mastitis are not 
entirely known. Data reported on cytokine expression following E. coli or LPS 
infection have been based on enzyme-linked immunosorbent assays (ELISA), which 
are limited by antibody availability and reagent development (e.g., generation of 
recombinant protein to be used as a standard). Proteomic analysis does not rely on 
antibodies however, and therefore is not limited to the detection of only a certain 
number of proteins. Previous attempts to characterize bovine milk proteins using a 




mastitis confirmed only by clinical parameters, or have involved the removal of 
highly abundant proteins prior to analysis. The desire to better understand underlying 
changes that occur in the mammary gland in response to invading pathogens, and the 
need to identify potential targets for new mastitis therapies coupled with advances in 
proteomic technology have led to investigations into the bovine milk proteome.  
Comparative analyses of bovine whey have been conducted using 2-dimensional gel 
electrophoresis (2D-GE) followed by matrix assisted laser desorption-ionization time-
of-flight (MALDI-TOF) mass spectrometry (Yamada et al., 2002; Hogarth et al., 
2004; Smolenski et al., 2007).  In the previous analyses, high-speed 
ultracentrifugation was used to produce the whey fraction analyzed (Yamada et al., 
2002; Smolenski et al., 2007) and the caseins were removed by either acid 
precipitation followed by dialysis (Hogarth et al., 2004) or by immunoabsorption 
(Yamada et al., 2002).  All previous analyses were successful in identifying the 
abundant whey proteins serum albumin, α-casein, β-casein, κ-casein, β-lactoglobulin, 
and α-lactalbumin.  Lower abundance proteins, including transthyretin and 
complement C3 α-chain were also identified in whey from three healthy mid-lactation 
cows (Yamada et al., 2002), but these analyses did not compare normal and mastitic 
whey samples and were limited in the number of low-abundance proteins identified 
despite prior sample clean-up. In comparative proteomic analyses of proteins in 
normal and mastitic whey, mastitis was established based on clinical parameters (heat 
in the gland, milk clots, swelling of udder) (Hogarth et al., 2004), or the analysis was 
conducted on samples from only one cow with a naturally occurring clinical infection 




al., 2007), that incorporated both a top-down proteomic approach using 2D-GE 
followed by mass spectrometry (MS), and a bottoms-up approach using liquid 
chromatography followed by MS (LC-MS) analysis of trypsin digested skim milk, 
whey, and milk fat globular membrane fractions, succeeded in identifying host 
defense related proteins.  However, a very small sample size was used (n=1), and 
either few peptides were sequenced or the proteins were only identified in one of the 
types of milk fraction analyzed (Smolenski et al., 2007). 
The goal of the current study was to utilize samples collected from a larger 
number of cows (n=8) with experimentally induced coliform mastitis, and to 
eliminate time consuming sample clean-up steps such as removal of high-abundance 
proteins and high-speed ultracentrifugation.  Caseins have been the principle target of 
high-abundance protein removal in sample preparation of milk from healthy cows. 
Since the removal of caseins requires acid precipitation followed by dialysis to 
remove acid traces, it is reasonable to theorize that both precipitation and dialysis 
could result in the loss of other proteins.    Following pathogen invasion and 
stimulation of the innate immune response, it has been well established that altered 
vascular permeability, as a result of local cytokine production, leads to leakage of the 
serum proteins into milk and the subsequent increase in the milk concentration of 
BSA.  Thus, the primary target of high-abundance protein removal in mastitic whey 
samples would be BSA.  A number of the commercially available serum albumin 
removal columns contain the non-specific dye ligand Cibacron Blue F3G-A, which 
efficiently binds serum albumin, but could also result in the loss of other proteins due 




molecules and proteins bind to serum albumin and thus, they could be lost as a result 
of serum albumin removal from samples (Gundry et al., 2007). In addition, other 
whey proteins including β-lactoglobulin have been shown to participate in the non-
specific binding of other ligands (Konuma et al., 2007) and thus it is reasonable to 
speculate that some milk proteins could become bound to a cellular component of the 
milk. Should a binding event occur, chances of a decrease in abundance or loss of 
proteins are increased with high- speed ultra-centrifugation. The goal of maintaining 
the large dynamic range of the milk proteins prior to proteomic analysis by 
minimizing potential protein losses during sample clean-up steps was to enhance the 
probability of identifying a greater number of differentially expressed proteins in 
mastitic versus normal whey samples.  The time points chosen for 2D-GE analysis in 
the study, prior to (time 0) and 18 h after E. coli infection, were based on previous 
reports indicating peak cytokine expression at or around 18 h following infection with 
E. coli (Bannerman et al., 2004), and preliminary 2D-GE  followed by MALDI-TOF-
MS analyses of a full time course (12, 18, 24, and 36 hours following infection) that 
revealed, on average, the most protein identifications and the highest level of 
differential protein expression to be at 18 h following infection with E. coli 
(Supplemental Fig.1).  Further knowledge of protein modulation during coliform 
mastitis could ultimately aid in the identification of biomarkers that could prove 
useful in evaluating the efficacy of adjunctive therapies in reducing inflammation 







Whey samples that were analyzed in the current study were obtained from an E. coli 
challenge study conducted at the Bovine Functional Genomics Laboratory at the 
USDA-Agricultural Research Service in Beltsville, MD.  Briefly, 8 clinically healthy 
Holstein cows in middle to late lactation were infected in one quarter with E. coli 
strain P4.  Preparation of the inoculum and experimental infection were performed as 
previously described (Bannerman et al., 2004).  Plating of aliquots of the final 
inoculum on blood agar plates confirmed that cows were infused with ~200 CFU’s of 
E. coli.  For the preparation of whey, milk samples were centrifuged at 44,000 x g at 
4ºC for 30 min and the fat layer removed with a spatula.  The skimmed milk was 
decanted into a clean tube, centrifuged again for 30 min, and the translucent 
supernatant collected and stored at –70ºC.  The use and care of all animals in this 
study were approved by the USDA-ARS Beltsville Agricultural Research Center’s 
Animal Care and Use Committee.   
 
2D- Gel Electrophoresis 
The protein content of the 0 hour (pre-infection) and 18 hour (post- infection) whey 
fractions from each cow (n=8) was determined with a Coomassie binding assay 
(Coomassie Plus Bradford Assay, Pierce Biotechnology, Rockford, IL) using BSA as 
a standard.  Approximately 200 μg of each whey protein sample was diluted in 
rehydration buffer (8 M urea, 2% CHAPS,  50 mM dithiothreitol (DTT), 0.2% 




Hercules, CA) to a final sample volume of 200 μl.  Following dilution in rehydration 
buffer, samples were applied to 11 cm pH 3-10 nonlinear immobilized pH gradient 
(IPG) strips (Bio-Rad Laboratories, Hercules, CA) and focused in a Bio-Rad Protean 
IEF Cell for 20 h using the following voltage intervals: 500 V for 1 h, 1000 V for 1 h, 
2000 V for 2 h, 4000 V for 4 h, and 8000 V for 12 h.  After focusing, IPG strips were 
equilibrated in buffer I, which consisted of 6 M urea, 2% SDS, 0.375 M Tris-HCl pH 
8.8, 20% glycerol, and 2% w/v DTT (Bio-Rad Laboratories, Hercules, CA), at room 
temperature for 30 min, then alkylated in buffer II which consisted of 6 M urea, 2% 
SDS, 0.375 M Tris-HCl pH 8.8, 20% glycerol, and 2.5% w/v iodoacetamide (Bio-Rad 
Laboratories, Hercules CA), at room temperature for 30 min.  The IPG strips were 
run in the second dimension on 10-20% Tris-HCl polyacrylamide gels (Bio-Rad 
Laboratories, Hercules, CA) in 1X Tris/Glycine/SDS buffer at 200 V for 1 h. Gels 
were fixed in 40% methanol (MeOH) /10% acetic acid for 1 h and then stained 
overnight in SYPRO® Ruby stain (Lonza, Walkersville, MD). Gels were destained 
twice in 10% MeOH/7% acetic acid for 1 h at room temperature and then imaged on a 
Typhoon™ 8600 multimode image scanner (GE Healthcare Bio-Sciences, 
Piscataway, NJ).  All samples were prepared in duplicate for a total of 2 gels per cow 
for both normal whey and mastitic whey. 
 
Tryptic Digestion 
Protein spots of interest were excised from the gel with a sterile 1000 μl pipet tip or a 
sterile stainless scalpel blade.  Only spots present in all gels from all cows for each 
time point were excised for identification. Identical spots from replicate gels were 




50% acetonitrile. Gel spots were dehydrated in 100% acetonitrile for 5 min at room 
temperature and then dried to completeness in a vacuum centrifuge for 20 min at 
22°C.  Spots were rehydrated in 15 μg/mL tryspin (Sigma-Aldrich, St. Louis, MO) in 
25 mM ammonium bicarbonate and allowed to digest for 16 h at 37°C.  Following 
digestion, peptides were extracted with 50% acetonitrile/5% trifluoroacetic acid 
(TFA) at room temperature for 1 h.  Peptides were concentrated in a vacuum 
centrifuge for 20 min at 22°C. 
 
MALDI-TOF MS and MALDI TOF/TOF PSD 
 
MALDI-TOF mass spectrometry was used to analyze tryptic peptides of digested 
proteins and MALDI-TOF/TOF post source decay (PSD) was used for peptide 
sequencing. Prior to analysis, 2 μl of digested sample was mixed with 2 μl of a 5 
mg/mL α-cyano-4-hydroxycinnamic (CHCA; Sigma-Aldrich, St. Louis, MO) solution 
prepared in 70% acetonitrile/0.1% TFA. One microliter of the 1:1 sample: matrix 
mixture was spotted in triplicate onto a stainless steel MALDI plate, and allowed to 
air dry. Mass spectra were acquired on a 4800 Plus MALDI TOF/TOF™ Analyzer 
(Applied Biosystems, Foster City, CA) in positive reflectron mode.  A mass range of 
900 to 4000 Daltons was used for MS analysis and a total of 100 shots were collected 
per spectrum at a laser intensity of 4100.  The 6 most intense ions per spectrum 
exhibiting a minimum signal to noise ratio of 10:1 were automatically selected for 
MS/MS PSD analyses.  A laser intensity of 4450 was used for PSD analyses and 100 





Protein Identification  
MALDI-TOF/TOF PSD spectra were searched against the “other mammalian” 
taxonomy of the Swiss Prot database using Mascot Daemon (v.2.1.0; Matrix 
Sciences, London, UK).  The enzyme used was set to trypsin, maximum number of 
missed cleavages allowed was 1, and the peptide mass tolerance was set at 0.5 
Daltons.  The fixed and variable modifications were carbamidomethyl and oxidation 
(methionine), respectively.  Protein identities reported by Mascot were individually 
inspected and matched to protein spots on the gels by comparing the precursor mass 
list for each spot recorded for each run on the instrument software with the charge-to-
mass ratio (m/z) of sequenced peptides on the Mascot search results report.  Unless 
noted, only proteins with a minimum of two unique peptides sequenced with Mascot 
identity scores greater than 30 were reported.   
 
Results 
Infection with E. coli Results in Differential Expression of Several Milk Proteins 
Whey from normal bovine milk samples (collected prior to infection with E. 
coli) and the whey fraction from mastitic milk samples (collected 18 h following 
infection with E. coli) were separated by 2D-GE and identified by peptide sequencing 
using MALDI-TOF/TOF PSD.  Variation in the protein profiles between cows was 
minimal, and thus representative gels from both normal and mastitic whey were 
chosen to illustrate the protein profiles generated in the current study.  Only protein 
spots clearly detected in all gels run on samples collected prior to or after infection 




whey samples from healthy cows (Table 1) and in mastitic whey samples (Table 2) by 
the sequencing of at least two peptides, with the exception of two proteins that had 
only one peptide sequenced.  
Normal bovine whey 2D-GE profiles (Fig. 1) exhibited an abundance of casein 
proteins, including α-S1-casein, β-casein, and κ-casein variants, and the whey 
proteins serum albumin, β-lactoglobulin, and α-lactalbumin. Also identified in whey 
from healthy cows were polymeric-immunoglobin receptor (PIGR) and several low 
abundance proteins including α-1-acid glycoprotein (A1AG), transthyretin, 
complement C3, epididymal secretory protein E1, lactadherin, fatty acid-binding 
protein (heart), and β-2 microglobulin. 
 
 
Figure 1 2D-GE SYPRO Ruby stained gel of normal bovine whey separated on an 11cm pH3-10 














Table 1 Proteins identified in normal bovine whey using MALDI-TOF PSD. 
 





  Spot 
ID 1   
Protein Name   Mr 2 Peptides Identified  Peptide   
Score   
MH+  3 
1   
  
Polymeric - immunoglobin 








GLNFDVSLEVSQDPAQASHAHVYTVDLGR   
89   
118   





2   
  
Serum Albumin   
  




88   
85   






3 ,6   
  
α - S1 - casein precursor   24570  HQGLPQEVLNENLLR  
EPMIGVNQELAYFYPELFR  
HPIKHGGLPQEVLNENLLR  
86   
94   






4   Complement C3 
precursor   
  




40   
111   





5   Lactadherin   
  




68   
116   




7 ,8,9    κ - casein   21370  YIPIQYVLSR  
HPHPHLSFMAIPPK. + Oxidation (M)  
SPAQILQWQVLSNTVPAK  
 
51   
31   




10 ,16,   
17,18   
ß - casein   
  
25148  DMPIQAFLLYQEPVLGPVR  
FQSEEQQQTEDE LQDL 
 
101   
113   
2186.60 
1982.17 
11   ß - lactoglobulin precursor   20269  LSFNPTQLEEQCHI  
YLLFCMENSAEPEQSLACQCLVR  
 
110   





12   Epididymal secretory 
protein E1 precursor   
16972  VVVEWELTDDKNQR  
 
 
96   1731.08 
13   α - lactalbumin   16692  VGINYWLAHQ  
ILDKVGINY WLAHK  
IWCKDDQNPHSSNICNISCDK  
65   
107   






14   Transthyretin   15831  TSESGELHGLTTEDKFVEGLYK  
SLGISPFHEFAEVVFTANDSGPR  
 
69   
107   
2440.37 
2477.34 
15   ß - 2 - microglobulin 
precursor   
13782  HVTLEQPR  
DWSFYLLSHAEFTPNSK  
HPPEDGKPNYLNCYVYGFHPPQIEIDLLK   
59   
78   





19   Fatty acid -binding 
protein, heart   
14827  SLGVGFATR  
LGVEFDETTADDR  
 
49   
86   
907.55 
1467.72 
20   α - 1 - acid glycoprotein   23453  WFYIGSAFR  
AIQAAFFYLER  
27   








In contrast, 2D-GE performed on mastitic bovine whey samples (Fig. 2A) 
revealed reduced abundance of α-S1-casein and β-casein, and the whey proteins β-
lactoglobulin and α-lactalbumin (Fig. 3) but a profound increase in bovine serum 
albumin. κ-casein variants were still evident in the mastitic whey, but in reduced 
amounts. Interestingly, spot 10 on the 2D-gels of mastitic whey appeared to be 
similar to spot 8 on the 2D-gels of normal whey, but the peptides sequenced from 
spot 10 were from apolipoprotein A-I.  Other highly abundant proteins found in 
mastitic whey included serotransferrin, fetuin (α-2-HS-glycoprotein), fibrinogen, and 
A1AG. Low abundance proteins identified in mastitic whey included α-1- 
antiproteinase, complement C3 and C4, transthyretin, protein S100- A12, and several 
antimicrobial peptides in the cathelicidin family including cyclic dodecapeptide 
(cathelicidin-1), indolicidin (cathelicidin-4), bactenecin-5 (cathelicidin-2), and 
bactenecin-7(cathelicidin-3), as well as apolipoproteins A-I, A-II, and C-III  (Fig. 
2B).   Levels of A1AG, transthyretin, and complement C3 levels appeared to increase 





















Table 2 Proteins identified in mastitic milk samples 18 hours post inoculation 































































































































































23 α-S1-casein precursor 24570 EPMIGVNQELAYFYPELFR + Oxidation 
 
66 2332.93 



































Figure 2 A) 2D-GE SYPRO Ruby stained gel of mastitic bovine whey separated on an 11cm pH3-10 
nonlinear IPG strip and 10-20% Tris-HCl SDS PAGE. B) 2D-GE of antimicrobial peptides and 
apolipoproteins. C) 2D-GE of variant forms of bovine serum albumin. Spot numbers correspond to 







Figure 3 Comparison of abundance levels of caseins, β-lactoglobulin and α-lactalbumin in normal (A) 
and mastitic (B) milk. Arrows indicate caseins which include α-S1, β, and κ, and β-lactoglobulin (β –





Other proteins including calbindin, acetylcholine receptor subunits beta and 
delta, matrix metalloproteinase-20, apolipoprotein A-IV, insulin-like peptide, 
lactotransferrin, and toll-like receptor 2 proteins were identified (data not shown) in 
normal and mastitic whey, but too few peptides were sequenced, and the Mascot 
identity scores were low.  
 
Serum Albumin is Present in Multiple Spots in Mastitic Whey Profiles 
2D-GE performed on whey samples collected 18 h following infection with E. 
coli revealed a marked increase in abundance of serum albumin.  In addition to intact 
serum albumin however, several smaller forms of BSA with varying mass and 
isoelectric points were present in mastitic whey samples (Fig. 2C). MALDI-TOF 
mass spectra of the abundant form of BSA found in normal whey and in mastitic 
whey (Mr ≈ 70kD) differed slightly in terms of intensity of select ions and mass of 
tryptic peptides (Fig. 4).  The most notable difference in the peptide mass maps of 
bovine serum albumin isolated from normal and mastitic whey samples was the 
presence a peptide with m/z 1749, which was unique to the spectrum of normal whey, 
and the presence a peptide with m/z 1724, which was apparent only in the spectrum 
from mastitic whey. Marked differences were apparent in the MALDI-TOF spectra of 
variant forms of serum albumin from mastitic whey samples however (Fig. 5), as the 
peptide with m/z 1479, which exhibits a high intensity in intact serum albumin in both 
normal and mastitic whey, was absent from MS spectra of two of the serum albumin 
variants (Spots 6 and 15).  Additionally, clear differences existed in the size and 




BSA. The peptide mass map of Spot 6 was characterized by the high intensity of the 
peptide with m/z 1511, as well as a peptide with an m/z 1166 that was not present in 
any other forms of BSA. The results indicate potential modifications of BSA in the 
mastitic whey samples that resulted in variance among the peptide mass maps. 
Figure 4 Comparison of mass spectra of the tryptic peptides generated from serum albumin in normal 
milk and in mastitic milk samples.  Normal milk serum albumin tryptic peptides differ slighty in mass 
and in intensity from serum albumin peptides in mastitic milk. 
 
 
Figure 5 Mass spectra of variant forms of serum albumin in mastitic milk samples. Both spectra lack 
the abundant serum albumin peptide with m/z 1479. The spectra of spot 6 contains a peptide found 









Alpha-1-Acid-Glycoprotein is Present in Both Normal and Mastitic Whey Samples 
Alpha-1-acid glycoprotein was the only acute phase protein identified in both 
normal and mastitic whey samples.  2D-GE profiles of whey from milk collected from 
all of the cows in the study (n=8) prior to infection with E. coli revealed low-abundance 
of A1AG. In contrast, 2D-GE of whey from milk collected 18 h following infection 
with E. coli revealed A1AG to be in relatively high-abundance. The identification of 
A1AG in whey from cows suffering from coliform mastitis has not been previously 
reported.   
 
Discussion 
Results of the current study demonstrate that exposure to E. coli profoundly alters 
milk protein profiles.  Additionally, the discovery of several low abundance proteins 
not previously reported in proteomic analyses of bovine milk (Yamada et al., 2002; 
Hogarth et al., 2004; Smolenski et al., 2007) indicates the success of the current 
methods in identifying differentially expressed milk proteins during coliform mastitis. 
In addition to the caseins α-S1, β, and  κ, the whey proteins β-lactoglobulin and α-
lactalbumin, and PIGR were all identified in these analyses as well as in previous 
proteomic analyses. Several other proteins were identified in whey samples from 
healthy cows however, that were not reported in earlier proteomic investigations of 
normal milk (Yamada et al., 2002; Hogarth et al., 2004; Smolenski et al., 2007) 
including lactadherin, fatty-acid binding protein (FABP), β-2 microglobulin, 
transthyretin (TTR), and epididymal secretory protein E1.  While lactadherin and FABP 




these proteins were identified in proteomic studies of normal whey.  Lactadherin and 
FABP are known to be abundant in the milk fat globular membrane (Mather, 2000), and 
thus it is reasonable to deduce that the identification of these proteins could be due to 
trace remnants of the fat layer present in the normal whey.  Likewise, β-2 microglobulin 
was identified in colostrum (Smolenski et al., 2007), but not in normal whey.  Also 
identified in normal whey samples was epididymal secretory protein E1, also known as 
NPC2.  NCP2 is a small lysosomal glycoprotein secreted in milk that is involved in 
cholesterol uptake (Xu et al., 2007).  NPC2 has not been reported in previous 
investigations into the bovine milk proteome.  The definitive presence of NPC2 in these 
normal whey samples is speculative however, as only one peptide from the protein was 
successfully sequenced.  
The presence of TTR in normal whey samples is compatible with previous 
proteomic analyses (Yamada et al., 2002; Hogarth et al., 2004; Smolenski et al., 2007); 
however, using the methods described in these analyses, TTR was identified in both the 
milk of healthy cows and in cows with coliform mastitis. Other proteins not previously 
identified in proteomic analyses of mastitic whey that were identified in the current 
study include the complement factors C3 and C4, and the apolipoproteins A-II and C-
III. Complement C3 was previously identified in normal bovine whey (Yamada et al., 
2002), but in the current study complement C3 was identified in both normal and 
mastitic whey samples.  These findings are compatible with the previously well 
characterized role of the complement system in innate immunity (Rainard and Riolett, 
2006).  While the discovery of complement factors in both normal and mastitic whey is 




supportive of the success of the methods used in the current study to identify low 
abundance proteins without the prior sample clean-up. Additionally, apolipoprotein A-
II and C-III were not found in previous proteomic analyses (Yamada et al., 2002; 
Hogarth et al., 2004; Smolenski et al., 2007). Apolipoprotein A-II is known 
synonymously as bovine antimicrobial peptide-1 (BAMP-1) and has been shown to 
have antimicrobial properties (Motizuki et al., 1998). The acute phase protein serum 
amyloid A (SAA) belongs to the apolipoprotein family and SAA is known to be 
elevated during mastitis (Hirvonen et al., 1999; Eckersall et al., 2001; Grönlund et al., 
2005). Whether or not the apolipoproteins identified in the current study are present in 
mastitic milk as the result of an acute phase response, leakage into the gland from 
systemic circulation, or the result of another mechanism entirely requires further 
analyses.    
 The appearance of serum albumin, serotransferrin, fibrinogen, fetuin (α-2-HS-
glycoprotein), and α-1-antiproteinase in relatively high-abundance in the 2D-GE of 
mastitic whey in the current proteomic analyses supports the leakage of serum proteins 
into milk following cytokine production and altered vascular permeability of the 
mammary epithelium.  Serum albumin and serotransferrin have been identified 
previously in mastitic whey (Hogarth et al., 2004; Smolenski et al., 2007) as well as 
fibrinogen and fetuin (Smolenski et al., 2007); however, identification of α-1-
antiproteinase in mastitic whey has not been reported.   
The identification of several bovine antimicrobial peptides (AMP) using MALDI-
TOF/TOF PSD supports the influx of neutrophils into the mammary gland following E. 




neutrophils are a well characterized source of AMP belonging to the cathelicidin family 
and are released upon neutrophil degranulation in the mammary gland (Tomasinsig and 
Zanetti, 2005).  The identification of cyclic dodecapeptide (cathelicidin-1) in mastitic 
milk has been reported (Smolenski et al., 2007), but not indolicidin (cathelicidin-4), 
bactenecin-5 (cathelicidin-2), and bactenecin-7(cathelicidin-3), as reported in the 
current study.  Previous research on members of the cathelicidin family of host defense 
peptides has indicated that cathelicidins could function in the neutralization of 
endotoxin, as well as the down-regulation of pro-inflammatory cytokine expression 
(Scott et al., 2002; Wiese et al., 2003; Zanetti et al., 2004).  The identification of several 
members of the cathelicidin antimicrobial peptides in mastitic but not normal whey 
samples in these analyses support the notion that AMPs serve a role in host defense.  
As in previous proteomic analyses comparing normal and mastitic bovine whey 
(Hogarth et al., 2004; Smolenski et al., 2007), serum albumin was detected in both 
normal and mastitic samples. However, in the current study, multiple forms of serum 
albumin were detected in mastitic whey.    It is established that serum albumin levels 
increase dramatically in bovine milk during coliform mastitis, but there have not been 
previous reports of different isoforms of serum albumin in mastitic milk.  Previous 
investigations have however, demonstrated that albumin is synthesized and secreted by 
the bovine mammary gland, and that local expression of albumin in the mammary 
gland was increased both in mastitic mammary tissue, and following exposure to LPS, 
when compared to expression in healthy mammary tissue (Shamay et al., 2005).   Based 
on reported RT-PCR data, the sizes of mammary-derived albumin and albumin in 




sequence of the albumin expressed in the mammary gland was not determined. 
Differences in the peptide sizes, distribution, and relative intensities apparent in the 
MALDI-TOF spectra of tryptic fragments of albumin from normal and mastitic whey 
samples, as well as the variants of albumin detected in mastitic whey, could therefore 
have been due to potential structural differences between albumin produced in the 
mammary gland and albumin that leaked into the gland as a result of increased vascular 
permeability, but determination of such would require further investigation.  
Differences in the albumin MALDI spectra could also have been due to slight variance 
in conditions during the digestion stage, or the result of compounds bound to the serum 
albumin that might have affected tryptic digestion patterns. Serum albumin is known to 
bind and transport long chain fatty acids as well as other small molecules including 
bradykinin and interferons, and acute phase proteins including SAA and α-1-acid 
glycoprotein (Peters, 1977; Gundry et al., 2007).  Bovine serum albumin is also known 
to have 3 isoforms with slightly differing isoelectric points.  In a previous study, bovine 
serum albumin exhibited the same molecular weight but three different pI’s (5.4, 5.5, 
and 5.6) following 2D-GE (Chang et al, 2005).  Results of the current study however, 
indicate shifts in both the size and the pI of bovine serum albumin. The most likely 
explanation for the multiple forms of BSA apparent on the 2D gels of mastitic whey is 
proteolysis, which is consistent with previous findings that treatment with trypsin 
yielded several fragmented forms of BSA (Peters et al., 1975).  Fragments of BSA 
resulting from proteolysis did however retain the ability to bind ligands (Peters, 1977).  
Whether or not the obvious shift in mass and pI of the BSA fragments was in part due 




majority of the peptides sequenced from spot 16 were serum albumin peptides.   
Evidence of the potential binding of other proteins to serum albumin was evident in this 
spot in mastitic whey, as one highly intense peptide that was present in the spectrum 
from spot 16 and subsequently sequenced (m/z 1696) matched complement C3.  The 
explanation could be close proximity and therefore incomplete separation of the two 
proteins, or a binding event either before or after leakage into the mammary gland from 
systemic circulation.   
Perhaps the most promising discovery in these proteomic analyses, however, was 
the identification of A1AG in both normal and mastitic whey samples, and the apparent 
higher abundance of this acute phase protein (APP) in the mastitic samples.  Previous 
analyses of APP expression during bovine mastitis have revealed increases in A1AG, 
SAA, LPS-binding protein (LBP), and haptoglobin (Hp) levels in serum (Hirvonen et 
al., 1999; Hiss et al., 2004; Bannerman et al., 2004; Grönlund et al, 2005), but the only 
acute phase proteins to be identified in mastitic milk were SAA, LBP, and Hp 
(Eckersall et al., 2001; Hiss et al., 2004; Bannerman et al., 2004).  A more recent study, 
however, identified A1AG in colostrum and normal milk of cattle (Ceciliani et al., 
2005), and determined that A1AG was expressed in mammary tissue.  Likewise, there 
have been reports of the local expression of A1AG in human mammary epithelial cells 
(Gendler et al., 1982).  The identification of A1AG in normal whey is compatible with 
previous analyses (Ceciliani et al., 2005). The presence of A1AG in mastitic whey 
however, has not been previously reported, but it is congruent with reports of increased 




into the milk as a result of altered vascular permeability (Eckersall et al., 2001; Hiss et 
al., 2004; Bannerman et al., 2004).   
In the present study, 2D-GE performed on whey samples both prior to inoculation 
with E. coli and 18 hours following infection revealed protein profiles with marked 
differences.  A greater number of differentially expressed proteins in mastitic versus 
normal whey were identified than in previous analyses that utilized 2D-GE followed by 
MS (Hogarth et al., 2004; Smolenski et al., 2007).  The most likely explanation is that 
no sample clean-up steps were employed in the analyses reported here, which reduced 
protein loss and allowed for the identification of a greater number of proteins.  The 
hypothesis regarding the number of proteins identified is supported by the success of a 
more recent proteomic analysis of several types of milk fractions (Smolenski et al, 
2007) in identifying a greater number of milk proteins related to host defense despite 
the lack of sample clean-up prior to analysis.  The number of cows sampled in the 
current study was much larger than previous analyses, and mastitis was experimentally 
induced so as to enable controlled analysis of changes in milk protein composition in 
response to infection.  Both the larger sample size used and the experimental induction 
of mastitis improve the potential of the current study for discovering protein 
biomarkers, while reducing the risk of reporting a host defense response unique to only 
one or a small number of cows.  Peptide identity scores are likewise an important 
parameter when considering the stringency of protein identification.  Previous 
proteomic analyses failed to report scores associated with protein identification 
(Yamada et al., 2002; Smolenski et al., 2007) or the scores reported were based on 




scores reported in the current study are robust and the protein identification criteria 
more stringent.  The methods and experimental design of the present study have 
demonstrated success in producing a more complete proteomic profile of milk protein 
changes during coliform mastitis, and have provided candidates for future research into 














Chapter 5:  Proteomic Analysis of the Temporal Expression of 
Abundant Bovine Milk Proteins during Coliform Mastitis using 
a Label-Free Approach. 
Abstract 
Previous studies have used proteomic approaches to evaluate the differential 
expression of proteins in milk from clinically healthy cows and from those with 
experimentally induced coliform mastitis.  Earlier studies, however, have been 
limited to the analysis of only one time point during infection and have lacked 
quantification of protein modulation.  The objectives of the current study were to 
evaluate the use of liquid chromatography coupled with tandem mass spectrometry 
(LC-MS/MS) to analyze changes in the temporal expression of abundant bovine milk 
proteins during the course of Escherichia coli intramammary infection, and to utilize 
a label-free semiquantitative approach to evaluate change in relative abundance of 
identified proteins. An additional objective was to compare observed trends in protein 
modulation detected using LC-MS/MS with those detected by ELISA, so as to 
investigate the feasibility of using a non-antibody based approach to track changes in 
biomarker expression during mastitis. LC-MS/MS conducted on whey from milk 
samples, collected just prior to infusion with E. coli and at 12, 18, 24, 36, 48, and 60 
hours following infection, resulted in the identification of the high to medium 
abundance proteins αS1-, β-, and κ-casein, and the whey proteins serum albumin, β-
lactoglobulin and α-lactalbumin.  Additionally, a select number of low abundance 




(A1AG), complement factor C3, apolipoproteins A-I and A-II, fibrinogen, 
glycosylation-dependent cell adhesion molecule-1 (Glycam-1), peptidoglycan 
recognition receptor protein (PGRP) and cathelicidin-1 were also identified.  Two 
methods for determining relative protein abundance, spectral counts and number of 
unique peptides, were compared and the latter used to evaluate temporal changes in 
milk proteins in response to infection.  For comparison with the proteomic-based 
methods of determining relative protein abundance, changes in serum albumin, 
lactoferrin, and transferrin in milk during mastitis were also measured using ELISAs. 
Label-free, proteomic-based quantification revealed relative changes in milk proteins 
that were comparable to expression profile changes detected by ELISA.  The results 
indicate that label-free LC-MS/MS methods are a viable means of tracking changes in 
relative protein abundance in milk, and that LC-MS/MS can be used to evaluate 
mastitis-associated temporal changes in the expression of bovine proteins for which 
no antibody or ELISA currently exists. 
Key Words: bovine milk proteome, liquid chromatography/tandem mass 





Characterization of the bovine milk proteome is a relatively new field in dairy 
cattle research, and to date has involved only a limited number of endeavors.  The 
earliest attempt to identify bovine milk proteins via a proteomic approach involved 
the use of liquid chromatography coupled with mass spectrometry (LC-MS) (Léonil 
et al., 1995); however, the findings of this study were limited by the absence of 
peptide sequencing data to support the authors’ identification of major milk proteins 
on the basis of molecular mass.  Efforts to further characterize the bovine milk 
proteome have included studies of normal bovine whey using 2-dimensional gel 
electrophoresis (2D-GE) to fractionate milk proteins, and liquid chromatography 
coupled with tandem mass spectrometry (LC-MS/MS) to identify low abundance 
proteins (Fong et al., 2008), as well as 2D-GE coupled to both matrix-assisted laser 
desorption/ionization time-of-flight (MALDI-TOF) and LC-MS/MS (Yamada et al., 
2002). Additionally, LC-MS/MS has been applied to the characterization of the 
bovine milk fat globule membrane (MFGM) proteome (Reinhardt and Lippolis, 2006; 
2008). Proteomic approaches have also been applied to investigations into markers 
for bovine disease including mastitis. Recent attempts to identify differentially 
expressed proteins and potentially novel protein biomarkers of host response during 
mastitis have utilized several proteomic strategies including 2D-GE followed by 
either MALDI-TOF mass spectrometry (Hogarth et al., 2004; Smolenski et al., 2007), 
or LC-MS/MS (Smolenski et al., 2007).   
The most reliable identifications made in nearly all prior bovine milk proteome 




α-S2-casein, β-casein, κ-casein, and the abundant whey proteins β-lactoglobulin, α-
lactalbumin, and serum albumin. Efforts, however, have been focused on the 
identification of proteins in bovine milk, and not on monitoring changes in expression 
over time, or over the course of infection. Likewise, while efforts to elucidate milk 
protein expression during cases of clinical mastitis have expanded our knowledge of 
protein modulation in bovine milk during mastitis, analyses have been limited to:  (1) 
identification of differentially expressed proteins at only one time point following 
experimental infection (Smolenski et al., 2007); (2) small sample sizes (Smolenski et 
al., 2007); or (3) cases of mastitis confirmed only by clinical parameters rather than 
the presence of a defined intramammary infection (Hogarth et al., 2004; Smolenski et 
al., 2007).  Assessments of temporal changes in bovine milk protein expression 
during clinical mastitis have been limited to examination of proteolysis in milk, and 
changes in serum albumin, lactoferrin, the caseins, β-lactoglobulin, α-lactalbumin, 
and the proteose peptone during experimentally induced coliform mastitis (Shuster et 
al., 1991; Moussaoui et al., 2004).  Changes in the concentration of lactoferrin, serum 
albumin, α-lactalbumin, and immunoglobin G (IgG) have also been monitored in milk 
from cows with both natural and experimental coliform mastitis (Harmon et al., 
1976). Additionally, many efforts have been made to measure changes in cytokine 
expression during experimentally induced mastitis (reviewed in Bannerman, 2009).  
Quantification of the abundant milk proteins has been accomplished using 
reverse-phase high performance liquid chromatography (RP-HPLC), but the methods 
developed were applied only to milk collected from healthy cows, and were not used 




the actual temporal expression of a limited set of milk proteins following 
experimental induction of coliform mastitis with Escherichia coli. 
The release of lipopolysaccharide (LPS) from gram negative bacteria in the 
mammary gland stimulates the release of cytokines and other inflammatory mediators 
that in turn induce dramatic changes in bovine milk protein profiles during coliform 
mastitis (Smolenski et al., 2007). Cytokines cause altered vascular permeability, a 
phenomenon that results in profound increases in levels of bovine serum albumin 
(BSA) in milk (Shuster et al., 1993; Bannerman et al., 2003; 2004), as well as other 
vascular derived proteins. Chemokines recruit polymorphonuclear neutrophils (PMN) 
to the site of infection in the gland, and upon degranulation these cells release 
cationic antimicrobial proteins into the milk (Tomasinsig and Zanetti, 2005), as well 
as acute phase proteins (Rahman et al., 2008).  Additionally, cytokines stimulate the 
hepatic production of acute phase proteins (APP; Dinarello, 1996; Eckersall et al., 
2001) as well as local production of APP in the mammary gland (Ceciliani et al., 
2005).    
To date, knowledge of cytokine expression in milk following E. coli infection or 
LPS challenge has been derived primarily from enzyme-linked immunosorbent assays 
(ELISA).  The chief limitation of utilizing methodologies such as ELISAs in marker 
discovery analyses, however, is that ELISAs are designed to measure only one 
protein at a time, and are limited by antibody development and availability.  
Currently, the number of commercially available bovine-specific antibodies is 
minimal compared to the number of antibodies available for human and conventional 




Conversely, proteomic methodologies are not reliant on antibodies and, thus, not 
restricted to the detection of only a select number of proteins (Lippolis and Reinhardt, 
2008).  Accurate quantification of the abundance of individual proteins identified in 
complex biological samples using proteomic strategies is, however, an emerging 
research area.  A popular means of quantifying proteins in a complex biological 
sample has been 2D-GE, but the “top down” approach using electrophoresis and 
quantification via densitometry is limited in sensitivity and problematic for proteins 
that are insoluble or have either a very high or low molecular weight (Old et al., 
2005). An alternative approach is “bottom up” or “shotgun” proteomics that involves 
the digestion of proteins in mixtures and subsequent analysis using LC-MS/MS.  
Several labeling strategies have been utilized in conjunction with LC-MS/MS 
analyses including: metabolic labeling commonly known as stable isotope labeling by 
amino acids in cell culture or SILAC (Ong et al., 2002); the use of synthetic standards 
such as the commercially available AQUA™ peptides (Stemmann et al., 2001); 
proteolytic labeling with 18O (Yao et al., 2003); or isotope incorporation by several 
means including chemical derivatization also known as isotope coded affinity tags or 
ICAT (Gygi et al., 1999), isobaric tags for relative and absolute quantitation (iTRAQ; 
Ross et al., 2004), or global internal standard technology (GIST; Chakraborty and 
Regnier, 2002).  Labeling strategies are cost limiting, not amenable to all biological 
matrices, and frequently require pairwise comparisons analysis between samples that 
renders retrospective assessments impossible (Old et al., 2005).  As a result, recent 
trends have been towards label-free relative quantification based on the comparison 




(Bondarenko et al., 2002; Old et al., 2005); (2) number of unique peptides identified 
for each protein in a sample (Liu et al., 2004); or (3) number of spectral hits (spectral 
counting) for each protein in a sample (Liu et al., 2004; Old et al., 2005; Zybailov et 
al., 2005).  
The goals of the current study were to profile temporal expression of abundant 
proteins in bovine milk samples collected over a time course following infection with 
Escherichia coli using LC-MS/MS, and to utilize a label-free approach to quantify 
relative changes in identified proteins. A further objective was to compare observed 
trends in protein modulation detected using LC-MS/MS versus ELISA to examine the 
accuracy of label-free quantification when used to track changes in the relative 




Eight clinically healthy multiparous Holstein cows in middle to late lactation (211 
DIM ± 12 d) were selected on the basis of milk SCC (MSCC) of < 200,000 cells/mL 
and no history of treatment for mastitis over the past 6 months.  The care and use of 
all animals in this study were approved by the University of Maryland’s Animal Care 







Determination of MSCC   
To quantitate somatic cells, milk samples were heated to 60ºC for 15 min and 
subsequently maintained at 40ºC until counted on an automated cell counter (Bentley 
Somacount 150; Bentley Instruments, Inc., Chaska, MN).  
Escherichia coli challenge and whey preparation  
Preparation of the inoculum and experimental infection were performed as 
previously described (Bannerman et al., 2004).  Following overnight incubation, 1mL 
of inoculum was serially diluted in phosphate-buffered saline (PBS) and plated on 
trypticase soy agar plates. Plates were incubated overnight at 37ºC and the stock 
solution maintained at 4◦C.  After determination of the stock culture concentration 
based on colony counts, the stock culture was diluted in PBS to a final concentration 
of approximately 40 CFU/mL. 
Baseline milk samples were collected aseptically from the right front quarter of 
each of the 8 cows the evening before and the morning of challenge. Following 
morning milking, the right front quarter of each of the 8 cows was infused with 2mL 
of 40CFU/mL of E. coli (~80CFU).  Milk samples were collected aseptically at 12, 
18, 24, 36, 48, and 60 hours following challenge. For the preparation of whey, milk 
samples were centrifuged at 4,000 rpm at 4ºC for 30 min and the fat layer removed.  
The skimmed milk was transferred to a clean tube, centrifuged again 20,000 x g at 
4ºC for 60 min, and the translucent supernatant collected, aliquoted into sterile 1.5mL 




ELISAs for BSA, Lactoferrin, and Transferrin 
Milk levels of bovine serum albumin (BSA) were determined using a 
commercially available ELISA kit (Bethyl Laboratories, Inc., Montgomery, TX) with 
slight modifications as previously described (Bannerman et al., 2003).  
Concentrations of lactoferrin, and transferrin in milk were determined using 
commercially available ELISA kits (Bethyl Laboratories, Inc., Montgomery, TX) just 
as previously described for BSA (Bannerman et al., 2003) with the slight 
modification that the wash and blocking buffers used were 50mM TBS with 0.05% 
Tween, pH 8.0, and 50mM TBS with 1 % BSA, pH 8.0 for both assays, respectively.     
Absorbance for all ELISAs were read at 450nm on a microplate reader 
(SpectraMax Plus, Molecular Devices, Sunnyvale, CA), and the concentration of 
BSA, transferrin, and lactoferrin calculated by extrapolating from a standard curve 
using SoftMax Pro software (v. 5.2, Molecular Devices, Sunnyvale, CA).  
In-Solution Digests 
The protein content of all of the whey fractions from each cow (n=56) was 
determined using a bicinchoninic acid assay (Pierce Biotechnology, Rockford, IL) 
with BSA as a standard.  Approximately 500 µg of each whey sample was diluted in 
0.5M triethylammonium bicarbonate (TEAB; Sigma Aldrich, St Louis, Missouri)/ 6M 
urea buffer to a final volume of 100µl.  Samples were reduced in a final concentration 
of 5mM tris(2-carboxyethyl)phosphine (TCEP; Promega, Madison, Wisconsin) for 
one hour at 37ºC.  Samples were alkylated in a final concentration of 10mM 




trypsin, samples were diluted with dH2O to reduce urea to a final concentration of 
<1M.  Approximately 5µg of sequencing grade modified trypsin (Promega, Madison, 
WI) was added to each sample to achieve a 1:100 enzyme-to-protein ratio, and 
digestion was carried out for 16 hours in a 37ºC water bath. Samples were acidified 
following digestion by the addition of acetic acid to a final concentration of 0.5%. 
LC-MS/MS analyses 
One-dimensional LC-MS/MS analyses were carried out by injecting 10 µL  of 
each whey digest into an ultra-pressure LC instrument (UPLC; Waters Acquity 
UPLC, Waters, Milford, Massachusetts) coupled to a quadrupole time-of-flight (Q-
TOF)  Premier mass spectrometer (Waters, Milford, Massachusetts).  Peptides were 
loaded onto a Symmetry NanoEase 300μm x 150mm C18 reverse phase HPLC 
column (Waters, Milford, Massachusetts). The mobile phase consisted of 0.1% 
formic acid in water (A) and 0.1% formic acid in acetonitrile (B). The gradient was 
100% A for 5 min and then ramped linearly to 60% B over 70 minutes at a flow rate 
of 20µL/ min. The Q-TOF mass spectrometer was equipped with an electro-spray 
ionization source (ESI) and was operated in positive ion mode with a capillary 
voltage of 3.0 kV.  Spectra were acquired for 70 minutes in data-dependent tandem 
MS mode.  The five most intense ions in each MS survey scan were subjected to 
MS/MS by collision-induced dissociation (CID). Collision energies used to fragment 
each peptide ion were based on the mass to charge (m/z) value of each peptide.  




Database searching and protein identification  
Mass spectral peak lists were extracted using Mascot Distiller and resulting peak 
lists were searched with the Mascot search engine (v.2.1.0; Matrix Sciences, London, 
UK) against the Swiss-Prot protein sequence library.  The following search 
parameters were applied: other mammalia species, trypsin enzyme, one allowed 
missed cleavage, carbamidomethylation fixed modification, methionine oxidation 
variable modification, precursor ion mass tolerance of ± 0.3 Da, and a fragment ion 
mass tolerance of ± 0.3 Da. The number of sequences searched in the other 
mammalia taxonomy was 10635.  Only peptides with a Mascot Ion Score equal or 
greater to the Identity Score (at P < 0.05) were included for identification. 
 
Label-free Quantification 
Label-free quantification was determined using both the number of unique peptides 
identified per protein and total peptides hits or spectral counts. Spectral counts are 
defined as the MS/MS sampling rate, or the total number of mass spectra assigned to 
peptides for a given protein (Liu et al., 2004).  The number of unique peptides 
identified, and the spectral counts for each protein, were determined using the software 
program MassSieve (Slotta et al., 2007; McFarland et al., 2008). Number of unique 
peptides was normalized relative to the total number of peptides identified in samples 
from all 8 cows at each sampling time point, and spectral counts were normalized 
relative to total peptide hits for all proteins identified at each time point (Florens et al., 
2006; Paoletti et al., 2006).  The average of the normalized values for spectral counts 




protein, and were expressed graphically as mean ± standard error (SE). To measure 
differences in protein abundance across time points, the fold-change between 
normalized spectral counts or number of unique peptides before and after challenge was 
calculated. Changes in relative abundance of proteins across the time points following 
infection with E. coli were considered relevant if the difference between pre- and post-
challenge normalized abundance factors was 2-fold or greater (Mosley et al., 2008). 
The 2-fold or greater level of significance was only applied to proteins that met the 
arbitrary threshold of greater than 5 peptide assignments per time point to avoid 
potential over-estimation of fold-changes in relative abundance of proteins with limited 
peptide assignments. For proteins not present in milk prior to challenge, peak 
expression was marked as the time point with the highest normalized abundance factor, 
and fold changes were measured relative to the time point at which the protein was first 
detected. 
Statistical analysis 
Repeated-measures analysis of variance was performed on ELISA data using the 
PROC MIXED model with Dunnett post hoc pairwise comparisons (SAS version 9.1; 
SAS Institute, Carey, N.C.) to compare changes in the proteins serum albumin, 
lactoferrin, and transferrin following infection to the pre-infection concentrations of 
each protein. Means and standard errors for all ELISA and label-free quantification 
data were calculated and graphed using SigmaPlot (v. 11.0 Systat Software, Inc., 
Chicago, IL). Means for normalized spectral counts and number of unique peptides 
identified for BSA were compared for significant differences using t-tests performed 




(MSCC) were log transformed to milk somatic cell scores (MSCS). For all statistical 
analyses, a value of P < 0.05 for the comparisons was considered to represent a 
significant difference between groups. 
 
Results 
Milk proteins identified in whey prior to and following infection with E. coli  
  Proteomic analyses of abundant bovine milk proteins before and after infection 
with E. coli revealed changes in the relative abundance of several milk proteins, as 
well as the appearance of proteins not present in milk prior to infection. Normal whey 
samples and whey samples collected at time points following experimental induction 
of coliform mastitis were both characterized by the presence of the abundant milk 
proteins α-S1-casein, β-casein, κ-casein, β-lactoglobulin, α-lactalbumin, and serum 
albumin; however, the number of unique peptides identified and the number of 
spectral counts for each peptide differed for each protein at the separate time points 
(Table 1). Although at lower frequencies, lactoferrin and glycosylation-dependent cell 
adhesion molecule-1 (glycam-1) were also identified in the milk of healthy cows and 
cows with mastitis (Table 2).  Proteins only identified in mastitic whey samples 
included transferrin, apolipoprotein A-I and A-II, and some extremely low abundance 
proteins detected transiently across different time points including fibrinogen, 
peptidoglycan recognition receptor protein (PGRP), fetuin (α-2-HS-glycoprotein), 
cyclic dodecapeptide (cathelicidin-1), indolicidin (cathelicidin-4), complement factor 





Table 1 Average spectral counts and number of unique peptides of abundant milk proteins. 





















ALBU_BOVIN Serum albumin 2 0.00329 12h 6 0. 01275 3.9
18h 12 0. 03011 9.2
24h 10 0. 02138 6.5
36h 13 0. 02130 6.5
48h 7 0. 01137 3.5
60h 5 0. 00885 2.7
LACB_BOVIN Β-lactoglobulin 8 0.05263 12h 7 0. 04687 0.9
18h 5 0. 04257 0.8
24h 5 0. 03556 0.7
36h 7 0. 03917 0.7
48h 8 0. 04462 0.9
60h 7 0. 04290 0.8
LALBA_BOVIN α- lactalbumin 3 0.02163 12h 2 0. 02030 0.9
18h 1 0. 01413 0.7
24h 1 0. 01226 0.6
36h 1 0. 00982 0.5
48h 1 0. 01009 0.5
60h 2 0. 01295 0.6
CASA1_BOVIN α-S1-casein 4 0.02368 12h 4 0. 02268 1.0
18h 4 0. 02812 1.2
24h 4 0. 02588 1.1
36h 6 0. 03021 1.3
48h 6 0. 02738 1.2
60h 5 0. 02709 1.1
CASB_BOVIN β-casein 1 0.00617 12h 1 0. 00677 1.1
18h 2 0. 01094 1.8
24h 2 0. 00989 1.6
36h 2 0. 00679 1.1
48h 2 0. 00930 1.5
60h 2 0. 00947 1.5
CASK_BOVIN κ- casein 2 0.01132 12h 2 0. 00958 0.9
18h 2 0. 01290 1.1
24h 2 0. 01499 1.3
36h 3 0. 01334 1.2
48h 2 0. 01234 1.1
60h 3 0. 01488 1.3  
a Average number of unique peptides identified across all 8 cows; b Normalized number of unqiue 





























TRFE_BOVIN Transferrin 0 0.00000 12h 1 0.00151 n/a
18h 1 0.00083 0.5
24h 1 0.00090 0.6
36h 1 0.00072 0.5
48h 0 0.00000 n/a
60h 0 0.00000 n/a
TRFL_BOVIN Lactoferrin <1 0.00022 12h <1 0.00064 2.9
18h 1 0.00138 6.3
24h 1 0.00089 4.0
36h <1 0.00036 1.6
48h 1 0.00184 8.4
60h 3 0.00419 19.0
GLCM1_BOVIN Glycam-1 1 0.00602 12h 1 0.00397 0.7
18h <1 0.00146 0.2
24h <1 0.00310 0.5
36h 1 0.00331 0.6
48h 1 0.00766 1.3
60h 1 0.00462 0.8
CTHL1_BOVIN Cathelicidin-1 0 0.00000 12h 0 0.00000 n/a
18h <1 0.00059 n/a
24h <1 0.00098 1.7
36h <1 0.00041 0.7
48h <1 0.00050 0.8
60h <1 0.00053 0.9
PGRP_BOVIN Peptidoglycan recognition 
receptor protein 0 0.00000 12h 0 0.00000 n/a
18h 0 0.00000 n/a
24h <1 0.00196 n/a
36h <1 0.00041 0.2
48h <1 0.00050 0.3
60h 0 0.00000 n/a  
a Average number of unique peptides identified across all 8 cows; b Normalized number of unique 
peptides; c Number of peptides <1 indicates only one peptide assignment in less than 8 cows;  d Fold-
change relative to pre-challenge levels, or the first time point detected. 
 
 
ELISA quantification of BSA, Lactoferrin, and Transferrin 
Increased permeability of the blood-milk barrier, a hallmark of coliform mastitis, 
was apparent by 18 h following infection as evidenced by increases in the vascular 




with E. coli exhibited significant (P < 0.05) differences in concentration at 18 h and 
24 h following infection when compared to levels detected in milk prior to infection 
(Fig. 1A).  BSA levels in milk from cows with coliform mastitis peaked at 18 h 
following infection, but returned to near baseline levels by 60 h.  Similarly, 
transferrin (Fig. 1B) was significantly increased (P < 0.05) when compared to 
baseline measurements at 18 h, 24 h, and 36 h following inoculation with E. coli,  but 
returned to pre-challenge levels by 60 h.  Lactoferrin concentrations in milk increased 
significantly (P < 0.05) when compared to pre-infection levels at 18 h, 24 h, 36 h, 48 
h, and 60 h, but unlike BSA and transferrin, did not return to baseline levels during 
the course of the study (Fig. 1C).  
 
Figure 1 ELISA results for BSA (A), transferrin (B), and lactoferrin (C) concentrations measured in 
milk. Means concentration (± standard error) are shown for each time point. * denotes significant 
changes (P<0.05) relative to time zero. 
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LC-MS/MS label-free quantification of abundant milk proteins 
The number of unique peptides that contributed to the identification of each milk 
protein, as well as the number of times each unique peptide was identified by MS/MS 
(spectral count), was determined for each protein using MassSieve (Table 1).  A 
comparison of normalized values for spectral counts and number of unique peptides 
identified for BSA (Fig. 2A), transferrin (Fig. 2B), and lactoferrin (Fig. 2C), revealed 
nearly identical temporal expression patterns. No significant differences (P > 0.05) in 
the means for each label-free measure were detected at any time point for any of the 
proteins. Although both methods yielded similar results, normalized spectral counts 
were less robust overall than normalized number of unique peptides. Thus, the 
number of unique peptides identified was utilized for the label-free quantification of 
all proteins throughout the rest of the analyses. 
Examination of the temporal expression of milk proteins before and after 
experimental induction of coliform mastitis revealed increases in the proteins albumin 
(Fig. 3A) and transferrin (Fig. 3B) at 18 h and 12 h, respectively, after infusion.  
Number of unique peptides identified for BSA at exhibited changes in relative 
abundance greater than 2-fold over pre-challenge levels at 12 h, 18 h, 24 h, 36 h, 48 h, 
and 60h following infection, but relative abundance at 60 h was approaching baseline. 
Less than five peptides were identified for transferrin, and thus no relevance was 
attributed to calculated fold-changes across time points.  Label free quantification of 
lactoferrin (Fig. 3C) revealed a gradual increase in relative abundance with time. As 
with transferrin, less than 5 peptides were assigned to lactoferrin and thus no 
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Figure 2 Comparison of normalized spectral counts and number of unique peptides identified at each 
time point for BSA (A), transferrin (B), and , lactoferrin (C). Means (± standard error) are shown for 
each time point.  
 
Profiles of milk samples also revealed a reduced abundance of the whey proteins 
β-lactoglobulin and α-lactalbumin, with the largest decreases evident between 12 and 
36 hours following infection, which corresponded with increases in serum albumin 
(Fig. 3D).   Changes in relative abundance of β-lactoglobulin and α-lactalbumin, as 
determined by number of unique peptides identified, were not greater than 2-fold 
compared to pre-infection levels, however, and were thus not considered significant. 
Likewise, abundance of α-S1-casein, β-casein, and κ-casein remained relatively 
unchanged throughout the course of the mastitis infection and no significant 
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Figure 3 Figure 2 Normalized number of unique peptides identified at each time point for BSA (A), 
transferrin (B), lactoferrin (C), whey proteins (D), and caseins (E). Means (± standard error) are shown 
for each time point. † denotes 2-fold or greater changes in abundance relative to time zero. 
 
LC-MS/MS Label free quantification is in accord with ELISA data 
The comparison of changes in milk concentrations of BSA following 
experimental induction of coliform mastitis as measured by ELISA and label-free 
LC-MS/MS quantification levels revealed significant differences from pre-challenge 
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levels at 18 h and 24 h for ELISA data, and at 12, 18, 24, 36, 48, and 60 h for label-
free quantification data (Fig. 4A).  Additionally, temporal expression patterns of BSA 
determined using an ELISA assay and normalized number of unique peptides 
identified by LC-MS/MS were nearly identical. Similar to the results found with 
BSA, the comparison of graphic representations of the quantification of transferrin 
(Fig. 4B) and lactoferrin (Fig. 4C) by ELISA versus label free LC-MS/MS methods 
revealed similar trends.  
 
Figure 4 Normalized number of unique peptides identified compared to ELISA data across time points 
for BSA (A), transferrin (B), and lactoferrin (C). Means (± standard error) are shown for each time 
point.  * denotes significant increases (P< 0.05) detected by ELISA, and † denotes greater than 2-fold 
increase in relative abundance of unique peptides. 
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LC-MS/MS label-free quantification of low abundance milk proteins comparess with 
clinical data. 
Temporal expression patterns of the antimicrobial proteins cathelicidin-1 and 
peptidoglycan recognition receptor (PGRP), before and after infection with E. coli 
were evaluated using normalized number of unique peptides identified per time point.  
Because expression of both antimicrobial proteins was transient, however, and few 
peptides assignments were made, the identification of cathelicidin-1 and PGRP must 
be regarded as tentative. Nonetheless, peak expression of both cathelicidin-1 and 
PGRP occurred at 24 h following infection (Fig. 5A), which corresponded to peak 
increases in milk somatic cell scores (Fig. 5B). MSCS were significantly elevated (P 







Figure 5 Comparison of the expression of antimicrobial proteins in milk with milk somatic cells 
scores. * denotes significant changes (P<0.05) relative to time zero. 
 
Discussion 
  Whey from bovine milk samples collected prior to infection with E. coli, and 
whey  from milk samples collected at 12, 18, 24, 36, 48, and 60 h following infection 




liquid chromatography, and identified by peptide sequencing using tandem mass 
spectrometry followed by database searching.  As the aim was to develop rapid 
throughput analyses of high to medium abundance milk proteins, no sample depletion 
was performed and only a one-dimensional separation was employed.  In accord with 
previous proteomic analyses that did not involve sample clean-up, the abundant milk 
proteins BSA, β-lactoglobulin , α-lactalbumin, α-S1-casein, β-casein, and κ-casein 
were identified in whey samples at all time points from all 8 cows (Smolenski et al., 
2007). 
ELISAs were used to evaluate the temporal expression of the proteins BSA, 
transferrin, and lactoferrin. Consistent with previously published results, expression 
of all 3 proteins increased in milk during mastitis (Rainard, 1983; Bannerman et al, 
2004). Compared to pre-challenge levels, significant increases in all 3 proteins were 
detected at 18 and 24 h following infection, and increases in transferrin and 
lactoferrin persisted until 36 and 60 h after infection, respectively.  While increases in 
levels of BSA (Fig. 1A) and transferrin (Fig. 1B) gradually started to decrease back 
towards baseline levels ≥36 h after infection, levels of lactoferrin (Fig. 1C) continued 
to increase throughout the study. The most probable explanation is that lactoferrin is 
produced locally by mammary epithelial cells in response to LPS (Pareek et al., 2005; 
McClenehan et al., 2005), whereas BSA and transferrin are serum derived proteins 
produced primarily in the liver that leak into the milk due to increased vascular 
permeability in the bovine mammary gland during inflammation (Shuster et al., 1993; 
Bannerman et al., 2003; 2004). Expression levels of the key inflammatory cytokines 




around 16 hours following experimental induction of coliform mastitis and to then 
decline steadily back towards basal levels (Bannerman et al., 2004). Thus, the effects 
of cytokine expression on vascular permeability could have diminished significantly 
by 36 h following infection.  
In-solution digests of whey proteins from milk collected prior to and following 
experimental induction of coliform mastitis were analyzed using LC-MS/MS, and 
data files generated from searching peak lists against the Swiss-Prot protein library 
using the Mascot search engine were distilled using MassSieve, an in-house software 
program (Slotta et al., 2007; McFarland et al., 2008). The number of unique peptides 
identified for each abundant protein, and affiliated spectral counts for each peptide, 
were normalized (Florens et al., 2006; Paoletti et al., 2006) and plotted over time to 
evaluate temporal expression of each protein.  Comparison of expression profiles 
generated using the normalized number of unique peptides with normalized spectral 
counts for each peptide revealed no significant differences in the label-free methods 
for determining temporal expression profiles of BSA, transferrin, or lactoferrin.  
Despite the fact that no significant differences were found between the mean number 
of unique peptides identified and the spectral counts for each peptide, the unique 
peptide data appeared slightly more robust than the spectral count data after 
normalization.   
Intramammary infection with E. coli resulted in changes in the temporal 
expression patterns of the abundant milk proteins BSA (Fig. 3A), β-lactoglobulin and 
α-lactalbumin (Fig. 3D), and in lesser abundant proteins, including lactoferrin (Fig. 




transferrin detected using LC-MS/MS label-free quantification, as well as the variable 
identification of other hallmarks of inflammation including fibrinogen, complement 
component C3, and the acute phase protein α-1-acid-glycoprotein only in whey 
samples following infection with E. coli, supported the findings of previous 
proteomic analyses of mastitic bovine milk (Hogarth et al., 2004; Smolenski et al., 
2007). 
 Contrary to previous proteomic analyses that utilized 1D and 2D gel 
electrophoresis to profile changes in milk protein expression following experimental 
induction of coliform mastitis (Moussaoui et al., 2004), no apparent fluctuations in 
the relative abundance of casein proteins were detected in this study using LC-
MS/MS to evaluate milk protein modulation during mastitis (Fig. 3E).  Possible 
explanations are the limitations of the amount of protein that can be analyzed using 
gel electrophoresis, and the fact that the majority of the total protein concentration of 
mastitic milk samples is BSA.  As a result, the accurate representation of the 
prevalence of other milk proteins on a 1 or 2D gel of mastitic bovine milk could be 
suppressed by the overabundance of BSA to the point that other proteins, such as the 
caseins, appear to be reduced in expression (Garbis et al., 2005). In all previous 
analyses, decreased casein expression during mastitis coincided with profound 
increases in levels of BSA in the milk (Moussaoui et al., 2004).  
Relative abundance of the milk proteins BSA, transferrin, and lactoferrin, as 
determined by the number of unique peptides identified by LC-MS/MS analyses, 
exhibited nearly identical expression patterns when compared to quantitative changes 




mastitis.  The primary difference between the two methods of elucidating temporal 
expression patterns of milk proteins during experimentally induced mastitis was the 
significance determined by statistical analyses of changes in abundance at the various 
time points following infection when compared to pre-challenge levels.  BSA, when 
measured using an ELISA, was shown to increase significantly (P< 0.05) relative to 
pre-challenge levels at both 18 and 24 h following infection, while significant fold 
changes in normalized number of unique peptides were apparent relative to 0 h at all 
time points after infusion (Fig. 4A). In contrast, an ELISA for transferrin revealed 
significant changes (P< 0.05) relative to basal levels at 18, 24, and 36 h following 
infection, but significance of fold-changes in normalized number of unique peptides 
for the time points during the mastitis infection relative to pre-infection levels could 
not be inferred because too few peptide assignments were made for transferrin (Fig. 
4B). Significant (P< 0.05) increases relative to 0 h were detected in lactoferrin at 18, 
24, 36, 48 and 60 h using an ELISA, but like transferrin, no inferences could be made 
regarding the significance of fold-changes in relative abundance due to insufficient 
peptide numbers (Fig. 4C).  
Label-free semiquantitative analyses are still considered an emerging research 
focus in the field of proteomics (reviewed in Mueller et al., 2008).  Most label-free 
quantification strategies are based on the hypothesis that the number of peptides 
identified for a given protein, and the MS/MS sampling rate of a specific peptide 
(spectral count), corresponds to the relative abundance of a particular protein in a 
complex mixture (Liu et al., 2004; Old et al., 2005; Zybailov et al., 2005).  




skewed, however, by the size and number of theoretical peptides a protein can yield, 
the actual abundance of the protein in a given biological matrix, the resolution and 
sensitivity of the instrument system, the physiochemical properties of a given peptide 
that enhance or suppress ionization and peptide observability, and the complexity of 
the biological sample (reviewed in Mueller et al., 2008). Normalization of number of 
peptides identified and spectral counts can, however, account for some of the inherent 
drawbacks to label-free semiquantitative analyses, including the size and number of 
peptides for a given protein (Florens et al., 2006; Paoletti et al., 2006).   
The number of peptides identified, and the number of times each peptide triggered 
an MS/MS event (spectral count), were nearly identical in the current protein data set  
There was, however, a large gap in the number of peptides identified for abundant 
whey proteins, and the number of peptide assignments for the remaining proteins 
identified.  The most likely explanation for the potential over-estimation of fold-
changes relative to pre-challenge levels for the protein BSA, when compared to 
significant increases in abundance detected using an ELISA, was the fact that the 
number of peptide assignments for BSA accounted for the majority of total peptides 
identified at each time point, with the exception of the pre-infection sample that was 
characterized by a greater abundance of β-lactoglobulin.  Thus, normalized 
abundance factors were likely skewed towards the relative abundance of BSA, except 
in whey from normal milk. Results of the analyses support previous demonstrations 
that the biological complexity of bovine milk before and after challenge varies greatly 




given sample, in addition to biological complexity, can affect the accuracy of 
semiquantitative analyses (Mueller et al., 2008; Simpson et al., 2009). 
The intense dynamic range of proteins present in bovine milk (O’Donnell et al., 
2004; Gagnaire et al., 2009), coupled with the yet unresolved method of accurately 
measuring changes in low abundance proteins present in complex biological matrices 
(reviewed in Mueller et al., 2008) presents a serious challenge for quantifying 
changes in low abundance proteins present in milk following infection.  Temporal 
expression patterns of milk proteins determined using ELISAs and mass spectrometry 
were, however, very similar for BSA, transferrin, and lactoferrin. Since the aim was 
to investigate the feasibility of using semiquantitative label-free strategies to evaluate 
the expression patterns of bovine milk proteins without the reliance on antibody-
based methodologies, label-free quantification was used to map the temporal 
expression of two transiently expressed low-abundance proteins involved in host 
response identified in whey following experimental induction of coliform mastitis.  
PGRP is a highly conserved pattern recognition molecule involved in innate 
immunity that has also been shown to interact with LPS, and to exhibit antibacterial 
activity in cattle (Dziarski, 2003; Tydell et al., 2006). Cathelicidin-1 is a cationic 
antimicrobial peptide also involved in innate immunity that is known to inactivate and 
destroy invading pathogens by perturbing microbial membranes (Scocchi et al., 
1997).  Both PGRP and cathelicidin-1 were identified in previous proteomic analyses 
of mastitic bovine milk (Smolenski et al., 2007), but changes in expression level 
during coliform mastitis were not evaluated. Based on normalized number of unique 




infection, while PGRP did not exhibit increased abundance until 18 h after infusion 
(Fig. 5A). Neutrophils are an established source of both PGRP and cathelicidin-1 
(Scocchi et al., 1997; Tydell et al., 2006), and are known to be the primary 
component of milk somatic cell counts (MSCC) during intramammary infection 
(Paape et al., 1981). Increases in MSCC (log transformed) were apparent starting 12 h 
following experimental induction of coliform mastitis, and counts peaked at 24 h after 
infusion (Fig. 5B). Thus, the increases in relative abundance of both PGRP and 
cathelicidin-1, determined using mass spectrometry, are in accord with clinical data. 
The comparison of relative abundance determined using mass spectrometric label-
free quantification to concentrations measured using an ELISA have not been 
reported for milk proteins.  However, milk proteins have been identified using LC-
MS/MS (Smolenski et al., 2007; Reinhardt and Lippolis, 2006; 2008), and differential 
expression of bovine milk proteins during mastitis has been investigated using 
proteomic strategies (Hogarth et al., 2004; Smolenski et al., 2007).  Additionally, 
there have been numerous reports on the evaluation of the expression of cytokines 
and soluble inflammatory mediators in milk during coliform mastitis (reviewed in 
Bannerman, 2009).  To date, quantification of milk protein and inflammatory marker 
expression during mastitis has been limited to antibody-based strategies such as 
ELISAs, and to polymerase chain reaction (PCR) measurements of mRNA levels 
(Bannerman et al., 2004; McClenahan et al., 2005; Vanselow et al., 2006).    
The primary limitation of established quantification methods is, however, that 
most are designed to measure only one protein in a sample at a time.  While 




proteins in any given sample, investigations into the quantification methods affiliated 
with mass spectrometry have not been initiated in studies of the bovine milk 
proteome.  Although the focus of the current study was primarily on abundant milk 
proteins, the temporal expression of some low abundance proteins associated with 
host response was possible using LC-MS/MS label-free quantification.  Biases were 
apparent, however, in the estimation of fold-changes in relative abundance of proteins 
across multiple time points following infection, despite normalization.  While the 
current study does represent the first longitudinal LC-MS/MS analyses of bovine milk 
samples before and after experimental induction of coliform mastitis, further research 
is required to address the impact of the dynamic range of bovine milk proteins, and 
the apparent fluctuations in biological complexity across time points following 
infection, on quantification of protein modulation during mastitis using 
semiquantitative label-free methodologies. Nonetheless, the analogous trends in 
temporal expression determined by the comparison of ELISA and mass spectrometric 
data are promising indications that LC-MS/MS analyses could prove useful in the 
evaluation of the modulation of bovine milk proteins as well as other inflammatory 
mediators during the course of coliform mastitis.  Of particular value would be the 
application of the label-free proteomic strategies to studies focused on the discovery 
of novel markers of disease in bovine milk using more sophisticated mass 
spectrometric analyses, and to the evaluation of milk proteins for which no bovine 




Chapter 6:  Label-free Quantification of Biomarkers of Host 
Response in Bovine Milk during Coliform Mastitis. 
 
Abstract 
Analyses of the bovine milk proteome following experimental induction of 
Escherichia coli mastitis have revealed profound changes in the relative abundance of 
milk proteins, as well as the presence of proteins related to host response. 
Identification of biomarkers of inflammation in bovine milk during intramammary 
infection has, however, been limited by the number of cows sampled, and the number 
of time points analyzed during a mastitis infection.  The objectives of the current 
study were to examine the temporal expression of low abundance biomarkers of host 
response in 8 cows across 4 time points following Escherichia coli challenge using 
nano-LC in line with nano-spray ion trap tandem mass spectrometry (LC-MS/MS), 
and to compare label-free methods of semiquantitiative analysis to evaluate changes 
in relative abundance of identified proteins.  Additionally, a goal was to compare 
trends in the modulation of select acute phase proteins (APP) in milk determined by 
ELISA and LC-MS/MS, to evaluate the accuracy of mass spectrometric-based label-
free quantification in depicting relative changes in biomarker expression during 
mastitis. LC-MS/MS conducted on whey from milk samples, collected just prior to 
infusion with E. coli and at 12, 18, 24, and 48 hours following infection, resulted in 
the identification of the high abundance proteins αS1-, αS2-,  β-, and κ-casein, and the 




vascular permeability, a hallmark of the inflammatory response associated with 
coliform mastitis, was evidenced by the presence of plasma-derived proteins in whey 
from mastitic milk including transferrin, complement factors C3, C4, and B, the 
apolipoproteins A1, A2, A4, and C3, fibrinogen -α, -β, and -γ chains,  hemopexin, 
alpha fetoprotein, and alpha-2-HS-glycoprotein. Hepatic production of APP was 
apparent by the detection of serum amyloid A (SAA), haptoglobin (Hp), inter-alpha 
trypsin inhibitor heavy chain-4, and α-1-acid glycoprotein.  Additional biomarkers of 
host response detected in bovine milk during mastitis included lactoferrin, kininogen 
1 and 2, osteopontin, glycosylation-dependent cell adhesion molecule-1, and the 
antimicrobial proteins cathelicidin-1, -2, -3, -4, -5, -6, -7, and peptidoglycan 
recognition protein. Normalized spectral abundance factors were used to track 
temporal changes in milk proteins in response to infection.  Changes in BSA, Hp, and 
SAA in the milk during mastitis were also measured using an ELISA for each protein. 
Label-free quantification revealed relative changes in milk proteins that were in 
accord with patterns observed by ELISA and with previously published data.  The 
results indicate that LC-MS/MS can be used to detect low abundance milk proteins 
that are biologically relevant to disease, and that NSAF are a viable non-antibody 
based method of monitoring changes during coliform mastitis in milk proteins for 
which no antibody or ELISA currently exists.   






Mastitis remains a principal focus of veterinary research due to staggering 
associated economic losses, insufficient means of early disease detection, and the lack 
of efficacious treatment options for intramammary infections caused by gram 
negative pathogens.   Specific obstacles associated with treating cases of coliform 
mastitis include: 1) inflammation caused by bacterial cell wall toxins for which there 
are no approved adjunctive therapies (Anderson, 1989; Wilson 1999); 2) vaccines 
against coliforms exhibit limited efficacy (Hogan et al., 1992); and 3) severe systemic 
complications that arise from the host inflammatory response (Eberhart et al., 1987).  
Attempts to better understand host response to gram negative pathogens have led to 
several investigations into the mediators of innate immunity in the bovine mammary 
gland (Paape et al., 1996; Lee et al., 2003; Bannerman et al., 2004; Petzl et al., 2008). 
Due to the prevalence of cases of coliform mastitis caused by Escherichia coli strains, 
E. coli has been used in several prior studies to experimentally induce coliform 
mastitis (Hirvonen et al, 1999; Lee at al., 2003; Bannerman et al., 2004). 
The focus of previous studies of bovine innate immunity during experimentally 
induced E. coli mastitis has primarily been soluble mediators of inflammation in 
bovine milk (reviewed in Bannerman, 2009).  Expression of inflammatory mediators 
during coliform mastitis is triggered by the release of lipopolysaccharide (LPS) from 
the cell wall of gram negative bacteria following intramammary infection (Shuster et 
al., 1993; Bannerman et al., 2003). Production of the cytokines IL-8 and TNFα by 
mammary epithelial cells (MEC) is an established response to LPS (Pareek et al., 




1β, IL-6, IL-8, and TNFα are all upregulated by LPS (Shuster et al., 1993; Bannerman 
et al., 2003), while in vivo studies have demonstrated that the cytokines IL-1β,  IL-8, 
and TNFα also increase in response to E. coli infection (Bannerman et al., 2004).  The 
majority of previously published data detailing the innate immune response in the 
bovine mammary gland during coliform mastitis has, however, been based on 
enzyme-linked immunosorbent (ELISA) assays. Despite their specificity, ELISAs 
have limited application in biomarker discovery due primarily to the fact that ELISAs 
measure only one protein at a time, and are restricted by the development and 
availability of species-specific antibodies.  Currently, the number of commercially 
available bovine-specific antibodies is limited compared to the number of antibodies 
available for human and conventional lab animal species. To overcome the reliance 
on antibody-based methodologies, recent efforts to elucidate protein modulation and 
mediators of inflammation in bovine milk during coliform mastitis have involved the 
application of proteomic methodologies to the evaluation of host response in the 
bovine mammary gland (Smolenski et al., 2007; Hogarth et al., 2004).   
Biomarkers of host response identified thus far in bovine milk using proteomic 
strategies include: lipocalin-type prostaglandin D synthase (Baeker et al., 2002); the 
acute phase proteins (APP) serum amyloid A (SAA; Smolenski et al., 2007); and, the 
antimicrobial proteins (AMP) peptidoglycan recognition receptor (PGRP) and 
cathelicidin-1 (Smolenski et al., 2007).  However, prior identifications of APP and 
AMP in bovine milk during mastitis have been in the milk fat globule membrane 
(MFGM) fraction (Smolenski et al., 2007).  Major limitations surrounding previous 




have been: identification of only a small number of proteins (Baeker et al., 2002; 
Hogarth et al., 2004); analyses of differentially expressed proteins at only one time 
point following experimental infection (Smolenski et al., 2007); a small number of 
cows sampled (Smolenski et al., 2007); or the incidence of mastitis confirmed only by 
clinical parameters (Smolenski et al., 2007; Hogarth et al., 2004).   Despite inherent 
shortcomings, previous proteomic analyses of milk from cows with clinical mastitis 
have nonetheless contributed significantly to our current knowledge of changes in 
bovine milk proteins during intramammary infection, and have expanded the 
somewhat limited annotation of the bovine milk proteome.   
Arguably, the most significant drawback to studies of the bovine milk proteome is 
the biological complexity of milk, an aspect made even more cumbersome by the 
numerous post-translational modifications (PTMs) that occur in milk proteins 
including glycosylation, phosphorylation, disulphide bond formation, and proteolysis 
(O’Donnell et al., 2004).  Additionally, analyses of the bovine milk proteome are 
hampered by the dynamic range of proteins in milk, which have been shown to vary 
in concentration by as much as a factor of 106 (O’Donnell et al., 2004; Gagnaire et al., 
2009).  Conventional approaches to reducing sample complexity prior to analyses, 
such as the removal of high abundance proteins or the fractionation of proteins or 
peptides in complex matrices, have to date been unsuccessful in studies involving the 
use of proteomic techniques to analyze bovine milk. Attempts to remove high 
abundance proteins, including casein depletion by acid precipitation and the removal 
of immunoglobulins by immunoaffinity, have resulted in a rather drastic reduction in 




Likewise, attempts to fractionate acidic and basic milk proteins using 2 dimensional 
gel electrophoresis (2D-GE) was hindered by carryover, and the identification of 
abundant proteins across multiple fractions (Fong et al., 2008).  Endeavors to reduce 
the complexity of bovine milk and affiliated subcellular fractions have resulted in 
more thorough comprehension of the complete bovine milk proteome, however, a 
tremendous gap in knowledge still exists regarding temporal expression of bovine 
milk protein modulation during disease (O’Donnell et al., 2004). 
A patent advantage of utilizing proteomic methodologies for biomarker discovery 
is that proteomics is not reliant on antibodies and can theoretically result in the 
detection of an unlimited number of proteins in any given sample (Lippolis and 
Reinhardt, 2008). However, there is still no gold standard for the accurate 
quantification of the abundance of individual proteins in complex biological samples 
using proteomic strategies, especially for proteins present in low abundance (Mueller 
et al., 2008).  Several labeling strategies are available for the quantification of 
proteins in conjunction with LC-MS/MS analyses, but labeling strategies can be cost 
limiting, often require pair wise comparisons which can be problematic when 
quantifying proteins that are only present in a given physiological state, and labeling 
strategies do not allow for retrospective quantification (Old et al., 2005). 
Consequently, label-free methods for the semiquantitative analysis of proteins in 
complex biological samples have been investigated including the comparison of: (1) 
the mean peak area of all peptides identified for each protein in a sample (Old et al., 
2005; Bondarenko et al., 2002); (2) number of unique peptides identified for each 




counting) for each protein in a sample (Old et al., 2005; Zybailov et al., 2005; Liu et 
al., 2004).  Label-free methods have gained popularity primarily because there are no 
associated costs, normalization allows for comparisons of protein abundance across a 
longitudinal set of samples, and analyses can be conducted retrospectively (Mueller et 
al., 2008). 
The aim of the current study was to expand existing knowledge of the expression 
of proteins related to host response present in bovine milk over the course of infection 
by analyzing milk samples collected from a group of 8 Holstein cows at multiple time 
points following inoculation with Escherichia coli.  A separate objective was to 
profile temporal expression of host response proteins in bovine milk by utilizing 
semiquantitative methods, and to compare trends in protein modulation detected 
using an LC-MS/MS label-free approach with changes in protein concentration 
detected using an ELISA for select proteins.  
 
Experimental Procedures 
Escherichia coli challenge and whey preparation  
The care and use of all animals in this study were approved by the University of 
Maryland’s Animal Care and Use Committee.   Eight clinically healthy multiparous 
Holstein cows in middle to late lactation (211 DIM ± 12 d) were selected on the basis 
of milk SCC (MSCC) of < 200,000 cells/mL and no history of treatment for mastitis 
over the past 6 months.  Preparation of the E. coli inoculum and experimental 




milk samples were collected aseptically from the right front quarter of each of the 8 
cows the evening before and the morning of challenge. Following morning milking, 
the right front quarter of each of the 8 cows was infused with 2mL of 40CFU/mL of 
E. coli (~80CFU).  Milk samples were collected aseptically at 12, 18, 24, and 48 
hours following challenge. For the preparation of whey, milk samples were 
centrifuged at 4,000 rpm at 4ºC for 30 min and the fat layer removed.  The skimmed 
milk was transferred to a clean tube, centrifuged again 20,000 x g at 4ºC for 60 min, 
and the translucent supernatant collected, aliquoted into sterile 1.5mL 
microcentrifuge tubes, and stored at –80 oC. 
 
ELISAs for BSA, Haptoglobin, and Serum Amyloid A  
Milk levels of BSA were determined using a commercially available ELISA kit 
(Bethyl Laboratories, Inc., Montgomery, TX) with slight modifications as previously 
described (Bannerman et al., 2003).  Milk levels of Hp were measured using a 
commercially available bovine sandwich ELISA kit (Immunology Consultants 
Laboratory, Inc., Newberg, OR) according to the manufacturer’s instructions, with 
modifications in the samples dilutions. The 0 and 12 hour whey samples were diluted 
1:50, and the remaining samples were diluted 1:200.  Milk levels of SAA were 
measured using a commercially available phase sandwich ELISA kit (Tridelta 
Development Ltd., Maynooth, Co. Kildare, Ireland) according to the manufacturer’s 
instructions, with modifications in the samples dilutions. The 0 and 12 hour whey 
samples were diluted 1:50 and the remaining samples were diluted 1:100.  




Plus, Molecular Devices, Sunnyvale, CA), and the concentration of BSA, SAA, and 
Hp calculated by extrapolating from a standard curve using SoftMax Pro software (v. 
5.2, Molecular Devices, Sunnyvale, CA). 
 
In-Solution Digests 
The protein content of all of the whey fractions from each cow (n=40) was 
determined using a bicinchoninic acid assay (Pierce Biotechnology, Rockford, IL) 
with BSA as a standard.  Approximately 100 µg of each whey sample was diluted in 
100mM ammonium bicarbonate (Sigma Aldrich, St Louis, Missouri) to a final 
volume of 50µl.  Samples were reduced in a final concentration of 5mM tris(2-
carboxyethyl)phosphine (TCEP; Promega, Madison, Wisconsin) for one hour at 37ºC.  
Alkylation was performed using a final concentration of 10mM iodoacetamide for 
one hour at room temperature with the samples protected from light.  Approximately 
1µg of sequencing grade modified trypsin (Promega, Madison, WI) was added to 
each sample to achieve a 1:100 enzyme-to-protein ratio, and digestion was carried out 
for 16 hours in a 37ºC water bath. Samples were diluted 1 to 1,000 in 0.5% acetic acid 
prior to analysis. 
 
Chromatography and Mass Spectrometry 
One-dimensional LC-MS/MS analyses were carried out by injecting 5µL  of each 
diluted whey digest into an ultra-pressure nano-LC instrument (nano-UPLC; Waters 
Nano Acquity UPLC, Waters, Milford, Massachusetts) coupled to a linear ion trap 
LTQ XL mass spectrometer (Thermo Fisher Scientific, Waltham, Massachusetts).  




(Waters, Milford, Massachusetts). The mobile phase consisted of 0.5% acetic acid in 
water (A) and 0.5% acetic acid in 80% acetonitrile (B). The gradient was 0 to 20%B 
for 1 min, 20-50% B in 42 min and 50-100% B in 5 min at a flow rate of 500nL/min. 
The LTQ mass spectrometer was equipped with a nano-electrospray ionization source 
(nano-ESI) and was operated in positive ion mode with a capillary voltage of 1.3V.  
Spectra were acquired for 80 minutes in data-dependent tandem MS mode.  The ten 
most intense ions in each MS survey scan were subjected to MS/MS by collision-
induced dissociation (CID). The collision energy used to fragment each peptide ion 
was 35kV.  Following MS/MS, precursor ions were excluded from MS/MS for 15 
seconds.   
 
Informatics 
Mass spectral peak lists were extracted using XCalibur and resulting lists 
searched with the Mascot search engine (v.2.1.0; Matrix Sciences, London, UK) 
against the Swiss-Prot protein sequence library.  The following search parameters 
were applied: other mammalia species, trypsin enzyme, one allowed missed cleavage, 
carbamidomethylation fixed modification, methionine oxidation variable 
modification, precursor ion mass tolerance of ± 1.3 Da, and a fragment ion mass 
tolerance of ± 0.8 Da. The number of sequences searched in the other mammalia 
taxonomy was 10635.  Only peptides with a Mascot Ion Score equal or greater to the 
Identity Score (at P < 0.05) were included for identification. 
Label-free quantification was determined using total peptides hits and spectral 




spectra assigned to peptides for a given protein (Liu et al., 2004).  Only proteins 
detected in 4 or more cows at a minimum of one time point following infection were 
included in the analyses. The number peptide hits (spectral counts) was determined 
for each protein using the software program MassSieve (Slotta et al., 2007; 
McFarland et al., 2008). Normalized spectral abundance factors (NSAF) were 
calculated based on spectral counts as previously described (Florens et al., 2006; 
Zybailov et al., 2006; Mosley et al., 2008), using the following formula:  
   
The average of the normalized values for spectral counts across all 8 cows was 
calculated for each identified protein and expressed graphically as mean ± standard 
error (SE).  To measure differences in protein abundance across time points, the fold-
change between NSAF before and after challenge was calculated. Changes in relative 
abundance of proteins across the time points following infection with E. coli were 
considered relevant if a 2-fold or greater NSAF were identified after challenge, or 
vice versa (McFarland et al., 2008; Mosley et al., 2008). The 2-fold or greater level of 
significance was only applied to proteins that met the arbitrary threshold of greater 
than 5 peptide assignments per time point to avoid potential over-estimation of fold-
changes in relative abundance based on small NSAF values. For proteins not present 
in milk prior to challenge, peak expression was marked as the time point with the 
highest NSAF value, and fold changes were measured relative to the time point at 
which the protein was first detected. Alignment of protein sequences, to determine the 
(NSAF)i = (Spectral Count / Length)i 





presence of two distinct protein isoforms, was carried out using the publicly available 
protein sequence alignment tool ClustalW (European Bioinformatics Institute, 
Cambridgeshire, UK). 
Statistical analysis 
Repeated-measures analysis of variance was performed on ELISA data using the 
PROC MIXED model with Dunnett post hoc pairwise comparisons (SAS version 9.1; 
SAS Institute, Carey, N.C.) to compare changes in select proteins related to host 
response identified in samples collected following infection to the pre-infection 
concentrations of each protein. Means and standard errors for all ELISA and label-
free quantification data (NSAF) were calculated and graphed using SigmaPlot (v. 
11.0 Systat Software, Inc., Chicago, IL). For all statistical analyses, a value of P < 




Bovine Milk Protein Modulation Following Infection with E. coli 
The two-fold aim of the study was to identify proteins related to host response in 
bovine milk samples from a group of 8 cows across multiple time points following 
experimental induction of coliform mastitis, and to quantify relative changes in 
protein abundance over the course of a clinical infection. Whey samples prepared 
from milk collected from 8 cows prior to infection (0 hour) and at 12, 18, 24, and 48 
hours following inoculation with E. coli were analyzed using one-dimensional nano-




bovine milk across all sample time points.  Of the proteins identified, 67 appeared in 
milk samples from multiple cows at more than one time point (Table 1), 20 appeared 
in multiple cows at only one time point (Supplemental Table 1), and 33 proteins 
appeared in only one cow across multiple time points. The remaining proteins 
identified were based on only one peptide assignment. Proteins identified in only one 
cow across multiple time points or by only one peptide were culled, because protein 
identifications were not considered robust, or were indicative of a response unique to 
only one animal. 
The most profound modulation in the composition of proteins present in the milk 
samples collected at time points following infection with E. coli was the presence of 
numerous vascular derived proteins including BSA, alpha-fetoprotein, transferrin, 
fibrinogen, several apolipoproteins, and complement factors. Another notable change 
in the protein content of the milk samples was the presence of the acute phase 
proteins SAA, Hp, and A1AG, as well as proteins with established antimicrobial 
properties including a number of cationic proteins belonging to the cathelicidin 
family, lactoferrin, lactoperoxidase, and peptidoglycan recognition receptor protein 
(PGRP). Additionally, proteins related to cell adhesion or lymphocyte trafficking 
including glycosylation-dependent cell adhesion molecule-1 (Glycam-1), alpha-2-HS-
glycoprotein, and osteopontin-K were detected in the whey from milk samples 










Table 1 Proteins identified in bovine whey from milk samples collected across time points 
following experimental induction of coliform mastitis. 




Protein Avg No. Cows 
Present  




Avg No.  
Peptides
Ref
ALBU_BOVIN P02769 Serum ablumin 8 5 30 18 1,2,3,
LACB_BOVIN P02754 β-lactoglobulin 8 5 37 9 1,2,3
CASA1_BOVIN P02662 α-S1-casein 8 5 18 5 1,2,3
CASA2_BOVIN P02663 α-S2-casein 8 5 8 4 1,2
CASB_BOVIN P02666 β-casein 8 5 5 3 1,2,3
CASK_BOVIN P02668 κ-casein 8 5 10 3 1,2,3
GLCM1_BOVIN P80195 Glycam-1 (Lactophorin) 8 5 7 3 1,2
TRFL_BOVIN P24627 Lactoferrin 8 5 20 15 1
LALBA_BOVIN P00711 α-lactalbumin 7 5 13 5 1,3
OSTP_BOVIN P31096 Osteopontin 7 5 2 2
TRFE_BOVIN Q29443 Transferrin 7 4 10 9 1,2,3
APOA1_BOVIN P15497 Apolipoprotein A1 7 4 9 8
CO3_BOVIN Q2UVX4 Complement C3 7 4 9 9 1
PIGR_BOVIN P81265 Polymeric immunoglobulin receptor 6 5 6 5 1,2
FETA_BOVIN Q3SZ57 Alpha-fetoprotein 6 5 1 1
FIT2_BOVIN A4FIN5 Fat-inducing protein 2 6 5 1 1
BT1A1_BOVIN P18892 Butyrophylin 5 5 3 3 1
LSM4_BOVIN Q3ZBK6 U6 snRNA-associated SM-like protein 5 5 1 1
SYMC_BOVIN Q2T9L8 Methionyl-tRNA synthetase 5 5 1 1
CC060_BOVIN Q2HJ12 Uncharacterized protein C3orf60 homolog 5 5 1 1
PGRP_BOVIN Q8SPP7 Peptidoglycan recognition receptor protein 5 4 4 4
CLUS_BOVIN P17697 Clusterin 5 4 3 3 1
CTHL1_BOVIN P22226 Cathelicidin-1 5 3 4 3
SAA_BOVIN P35541 Serum amyloid A 5 2 2 2
ACTG_BOVIN P63258 Actin, cytoplasmic 2 5 2 4 4
CRF_BOVIN Q95MI6 Corticoliberin 4 5 1 1
VTDB_BOVIN Q3MHN5 Vitamin D binding protein 4 4 2 2 1
APOA2_BOVIN P81644 Apolipoprotein A2 4 4 2 2
KNG2_BOVIN P01045 Kininogen 2 4 4 2 2
FETUA_BOVIN P12763 Alpha-2-HS-glycoprotein 4 4 3 3 1
CFAB_BOVIN P81187 Complement factor B 4 4 2 2
FIBA_BOVIN P02672 Fibrinogen alpha chain 4 4 7 6
FIBB_BOVIN P02676 Fibrinogen beta chain 4 4 4 3
FIBG_BOVIN P12799 Fibrinogen gamma chain 4 4 2 2 1
ITIH4_BOVIN Q3T052 Inter-alpha trypsin inhibitor heavy chain 4 4 4 2 2
PERL_BOVIN P80025 Lactoperoxidase 4 4 1 1 1,2
HEMO_BOVIN Q3SZV7 Hemopexin 4 3 2 2
ACTB_BOVIN P60712 Actin, cytoplasmic 1 4 3 6 5 2
CTHL2_BOVIN P19660 Cathelicidin-2 4 3 2 2
HPT_BOVIN Q2TBU0 Haptoglobin 4 3 2 2
CTHL4_BOVIN P33046 Cathelicidin 4 4 2 4 3
MFGM_BOVIN Q95114 Lactadherin 3 5 2 2
APOC3_BOVIN P19035 Apolipoprotein C3 3 4 1 1
B2MG_BOVIN P01888 Beta-2-microglobulin 3 4 2 2 1,2
GELS_BOVIN Q3SX14 Gelsolin 3 4 1 1 1
CTHL6_BOVIN P54228 Cathelicidin-6 3 3 2 2
CTHL7_BOVIN P56425 Cathelicidin-7 3 3 2 2
THRB_BOVIN P00735 Prothrombin 3 3 1 1
CTHL3_BOVIN P19661 Cathelicidin 3 3 2 2 2
CTHL5_BOVIN P54229 Cathelicidin 5 3 2 2 2
A1AG_BOVIN Q3SZR3 Alpha-1-acid glycoprotein 2 4 1 1
BT3L4_BOVIN Q2KIY7 Transcription factor BTF3 homolog 4 2 4 1 1
KNG1_BOVIN P01044 Kininogen 1 2 3 2 2 1
ITIH1_BOVIN Q0VCM5 Inter-alpha trypsin inhibitor heavy chain 1 2 3 1 1
APOE_BOVIN Q03247 Apolipoprotein E 2 3 3 3
UBC12_BOVIN A3KN22 NEDD8-conjugating enzyme Ubc12 2 5 1 1
GPC5C_BOVIN Q2YDG0 G-protein coupled receptor family group 5-C 2 2 1 1
ITIH5_BOVIN A2VE29 Inter-alpha trypsin inhibitor heavy chain 5 1 4 1 1
CENPH_BOVIN Q3T0L1 Centromere protein H 3 4 1 1
NUCB1_BOVIN Q0P569 Nucleobindin-1 2 2 1 1
B4GT1_BOVIN P08037 Beta-1,4-galactosyltransferase 1 2 3 1 1
XDH_BOVIN P80457 Xanthine dehydrogenase 2 2 2 2
OSTK_BOVIN P31098 Osteopontin-K 3 3 2 2
APOA4_BOVIN Q32PJ2 Apolipoprotein A-IV 2 3 2 2
APOH_BOVIN P17690 Beta-2-glycoprotein 1 2 2 1 1
PTGDS_BOVIN O02853 Prostaglandin-H2 D-isomerase 1 3 1 1 4
ANT3_BOVIN P41361 Antithrombin-III 2 2 1 1




Novel acute phase and inflammatory mediators were likewise identified.  Two 
isoforms of kininogen, the precursor to bradykinin, were identified in milk following 
infection with E. coli, as was the APP inter-alpha trypsin inhibitor heavy chain 4 
(ITIH4). Additional proteins related to host response not identified in earlier 
proteomic analyses that were identified in the current study included osteopontin, 
SAA, Hp, α-1-acid-glycoprotein, complement factor B, apolipoproteins A-I, A-II, A-
IV, and C-III, several cathelicidins, fibrinogen β-chain, and prothrombin (Table 2).   
In summation, a total of 48 proteins directly related to host response, or that are 
known to leak into milk from circulation as a secondary effect of cytokine production 
during coliform mastitis, were identified in milk following experimental induction of 
mastitis (Table 3). 
 





Protein Avg No. Cows 
Present  
No. Time Points 
Present
OSTP_BOVIN P31096 Osteopontin 7 5
APOA1_BOVIN P15497 Apolipoprotein A1 7 4
FETA_BOVIN Q3SZ57 Alpha-fetoprotein 6 5
SAA_BOVIN P35541 Serum amyloid A 5 2
CRF_BOVIN Q95MI6 Corticoliberin 4 5
FIBB_BOVIN P02676 Fibrinogen beta chain 4 4
APOA2_BOVIN P81644 Apolipoprotein A2 4 4
KNG2_BOVIN P01045 Kininogen 2 4 4
CFAB_BOVIN P81187 Complement factor B 4 4
ITIH4_BOVIN Q3T052 Inter-alpha trypsin inhibitor heavy chain 4 4 4
CTHL2_BOVIN P19660 Cathelicidin-2 4 3
HPT_BOVIN Q2TBU0 Haptoglobin 4 3
CTHL4_BOVIN P33046 Cathelicidin 4 4 2
APOC3_BOVIN P19035 Apolipoprotein C3 3 4
CTHL6_BOVIN P54228 Cathelicidin-6 3 3
CTHL7_BOVIN P56425 Cathelicidin-7 3 3
THRB_BOVIN P00735 Prothrombin 3 3
OSTK_BOVIN P31098 Osteopontin-K 3 3
CTHL3_BOVIN P19661 Cathelicidin 3 3 2
CTHL5_BOVIN P54229 Cathelicidin 5 3 2
A1AG_BOVIN Q3SZR3 Alpha-1-acid glycoprotein 2 4
APOA4_BOVIN Q32PJ2 Apolipoprotein A-IV 2 3
APOE_BOVIN Q03247 Apolipoprotein E 2 3






Table 3 Proteins related to host response identified in bovine milk following infection with 
E.coli 
Sw iss-Prot entry 
name
Protein Funct ion
ALBU_BOVIN Serum albumin Main plasma protein; binds Ca2+, Na+, K+, fatty acids
GLCM1_BOVIN Glycam-1 (Lactophor in) Mediates trafficking of lymphocytes to lymph nodes
TRFL_BOVIN Lactoferrin Iron-binding protein; has antimicrobial activit y
OSTP_BOVIN Osteopontin Enhances production of interferon-gamma and inter leukin 12
TRFE_BOVIN Transferrin I ron-binding protein
APOA1_BOVIN Apolipoprotein A1 Major plasma HDL protein
CO3_BOVIN Complement C3 Major protein in complement activation
FETA_BOVIN Alpha-fetoprotein Plasma protein; binds copper, nickel, and fatty acids
PGRP_BOVIN Peptidoglycan recognition receptor protein Involved in innate immunity; microbicidal for gram(+) and gram (-) bacteria
CLUS_BOVIN Clusterin Function unclear:  may be involved in programmed cell death
CTHL1_BOVIN Cathelicidin-1 Potent microbicidal activity against E. coli
SAA_BOVIN Serum amyloid A Major acute phase protein
VTDB_BOVIN Vitamin D binding protein Associates w/immunoglobulins on lymphocytes
APOA2_BOVIN Apolipoprotein A2 Stablizes HDL; has antimicrobial activity
KNG2_BOVIN Kininogen 2 Produces active peptide bradykinin;  inflammatory mediator
FETUA_BOVIN Alpha-2-HS-glycoprotein Promotes endocytosis; has lymphocyte stimulting properties
CFAB_BOVIN Complement factor B Part of the alternative complement pathway
FIBA_BOVIN Fibrinogen alpha chain Yields monomers that polymerize into f ibrin; acts a cofactor in platelet aggregation
FIBB_BOVIN Fibrinogen beta chain Yields monomers that polymerize into f ibrin; acts a cofactor in platelet aggregation
FIBG_BOVIN Fibrinogen gamma chain Yields monomers that polymerize into f ibrin; acts a cofactor in platelet aggregation
ITIH4_BOVIN Inter-alpha trypsin inhibitor heavy chain 4 Involved in acute phase reactions
PERL_BOVIN Lactoperoxidase Antimicrobial agent; protects udder from infection
HEMO_BOVIN Hemopexin Binds heme and transports it to the liver 
CTHL2_BOVIN Cathelicidin-2 Potent antimicrobial activity
HPT_BOVIN Haptoglobin Combines w/free plasma hemoglobin; acute phase protein
CTHL4_BOVIN Cathelicidin 4 Potent microbicidal activity against E. coli
APOC3_BOVIN Apolipoprotein C3 Inhibits lipoprotein lipase and hepatic lipase
B2MG_BOVIN Beta-2-microglobulin Beta chain of major histocompatibility complex class I molecules
CTHL6_BOVIN Cathelicidin-6 Potent antimicrobial activity
CTHL7_BOVIN Cathelicidin-7 Potent antimicrobial activity
THRB_BOVIN Prothrombin Converts fibrinogen to fibrin; functions in inflammation
CTHL3_BOVIN Cathelicidin 3 Potent antimicrobial activity
CTHL5_BOVIN Cathelicidin 5 Potent antimicrobial activity
A1AG_BOVIN Alpha-1-acid glycoprotein Modulates activity of immune system during acute phase reaction
KNG1_BOVIN Kininogen 1 Produces active peptide bradykinin; inflammatory mediator
ITIH1_BOVIN Inter-alpha trypsin inhibitor heavy chain 1 May act as a carrier for hyaluronan in serum
APOE_BOVIN Apolipoprotein E Mediates binding, internalization, and catabolism of  lipoprotein par ticles
ITIH5_BOVIN Inter-alpha trypsin inhibitor heavy chain 5 May act as a tumor suppressor
OSTK_BOVIN Osteopontin-K Involved in cell adhesion
APOA4_BOVIN Apolipoprotein A-IV Involved in chylomicron and VLDL secretion and catabolism
APOH_BOVIN Beta-2-glycoprotein 1 Prevents blood coagulation cascade by binding to phospholipids on damaged cells
PTGDS_BOVIN Prostaglandin-H2 D-isomerase Prostaglandin; potent inhibitor of platelet aggregation
ANT3_BOVIN Antithrombin-III Serin protease; regulates blood coagulation cascade
CD36_BOVIN Platelet glycoprotein 4 May function as cell adhesion molecule; binds collagen and anionic phospholipids
LBP_BOVIN Lipopolysaccharide-binding protein Binds LPS; interacts with CD14
DFB11_BOVIN Beta-defensin 11 Potent microbicidal activity against E. coli
A2MG_BOVIN Alpha-2-macroglobulin Inhibits proteinases









LC-MS/MS Label-free quantification using number of unique peptides versus spectral 
counts 
A comparison of label-free quantification performed using normalized number of 
unique peptides and normalized spectral counts revealed differences in the 
semiquantitative measures of protein abundance at early time points for the proteins 
serum albumin (Fig. 1A) and β-lactoglobulin (Fig. 1B), but better uniformity of 
quantitative measures at later time points.  In contrast, nearly identical expression 
patterns were observed between number of unique peptides and spectral counts for 
the low abundance proteins osteopontin (Fig. 1C) and complement factor B (Fig. 1D).  
Normalized spectral abundance factors correspond with total ion intensity data 
A comparison of relative abundance determined using spectral counts versus total 
ion current intensity was performed using NSAF and extracted ion chromatograms 
(XIC) for both the highly abundant protein BSA (Fig. 2A) and the low abundance 
protein haptoglobin (Fig. 2B).  XIC were carried out on 2 BSA peptides and 1 Hp 
peptide. Only 1 Hp peptide was used because despite the multiple peptides that were 
assigned to Hp, only one peptide consistently contributed to the identification of Hp 
across multiple samples and time points. Relative abundance of BSA across all time 
points, as determined using both spectral counts and XIC, were nearly identical in 
pattern. Furthermore, peak increases in the abundance of BSA were apparent at 24 h 
following challenge relative to pre-infection levels using both XIC and NSAF. 
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determined using XIC and NSAF exhibited patterns of estimated relative abundance 





Figure 1 Comparison of label-free quantification using normalized number of unique peptides and 
normalized spectral abundance factors for the high abundance proteins serum albumin (A) and β-





Figure 2 Comparison of relative quantification and determined using normalized spectral abundance 
factors (NSAF) and total ion intensity of the high abundance protein BSA (A) and the low abundance 





LC-MS/MS Label free quantification corresponds with ELISA data 
To assess the feasibility of using NSAF to track changes in the relative abundance of 
proteins detected in bovine milk following infection with E. coli, NSAF for milk 
BSA, Hp, and SAA were compared to quantification of each protein determined using 
commercially available ELISAs. Overall, temporal expression patterns determined 
using an ELISA assay and NSAF were nearly identical for all 3 proteins. The 
comparison of changes in milk concentrations of BSA following experimental 
induction of coliform mastitis as measured by ELISA and NSAF revealed significant 
differences from pre-challenge levels at 18 h and 24 h for ELISA data, and greater 
than or approaching 2-fold changes in NSAF at the same time points (Fig. 3A).  
Increases in milk Hp were evident as early as 12 h following infection in both the 
NSAF and ELISA data, with peak increases apparent at 24 h (Fig. 3B).  SAA was 
detected in milk as early as 12 h following infection using an ELISA, but not until 18 
h using LC-MS/MS (Fig. 3C).  Levels of SAA continued to rise throughout the 
duration of the study, and did not return to baseline. SAA and Hp were much lower in 
abundance than BSA, however, and were not present in milk prior to infection.  Thus, 
detecting meaningful fold-changes in the APP was somewhat biased due to the 
limited number of peptides detected, the subsequently lower MS/MS sampling rates 
of assigned peptides, and the fact that baseline abundance values for each protein 
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Figure 3 Comparison of quantification by ELISA and normalized spectral abundance factors (NSAF) 
for serum albumin (A), haptoglobin (B), and serum amyloid A (C). * denotes a significant increase (P 
< 0.05) in abundance determined using ELISA, † denotes a 2-fold or greater increase determined using 
NSAF. 
 
Semiquantitative Analysis of Abundant Milk Proteins during Mastitis 
Relative abundance of the whey and casein proteins in milk was determined using 
NSAF. Profiles of whey proteins across all time points revealed increases in BSA 
beginning at 12 h, with greater than 2-fold changes at 18 and 24 h following infusion 
(Tables 4 & 5).  Reduced abundance of β-lactoglobulin and α-lactalbumin were 
evident between 12 h and 24 h following infection.  Fold changes were not 
significant, but decreased expression of β-lactoglobulin and α-lactalbumin 
corresponded to peak increases in BSA in the milk (Fig. 4A). In contrast, abundance 




but remained relatively unchanged after 24 h. No significant fold changes in relative 
abundance across time points were detected for any of the casein proteins (Fig. 4B).  
 
Figure 4 Temporal expression of normalized spectral abundance factors for whey and casein proteins. 
† denotes a 2-fold or greater increase determined using NSAF. 
 
Semiquantitative Analysis of Proteins related to Host Response in Milk during Mastitis 
Relative protein quantification of select proteins related to host response was 
determined using NSAF. Stringent thresholds were applied to the decision of which 
proteins to evaluate for temporal expression. Only proteins identified in 4 or more 
cows at multiple time points and with greater than one peptide observation were 
included in the analysis; proteins identified based on only one peptide assignment or 
in fewer than 4 cows were not considered. The types of host response proteins 
evaluated for temporal abundance patterns during clinical mastitis were vascular-
derived (Table 5), acute phase, and antimicrobial (Table 6). NSAF for the plasma 
proteins complement C3 and complement factor B (Fig. 5A), fibrinogen α, β, and γ 
chains (Fig. 5B), and the most abundant apolipoproteins, A-I and A-II (Fig. 5C), 
revealed peak increases in relative abundance at 18 hours following experimental 
induction of coliform mastitis for all of the proteins. 
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Fold changes in plasma-derived proteins could not be calculated relative to pre-
challenge levels because none of the proteins that presumably leaked into the milk as 
a result of increased vascular permeability, with the exception of BSA, were present 
in milk prior to infection. Fold changes were calculated using NSAF between the first 
time point the protein was identified and later time points, but for lower abundance 







Table 4 Normalized spectral abundance factors for whey and casein proteins before 
and after challenge. 
 P ro te in P re-
C halle nge  
Spe ct ral 
C ountsa
P re -
C halle nge   
N SAFb
Post -
Cha lle ng e  
Time  Point
Po st -
C halleng e 
Spe ctra l 
C ountsa
Po st-
C hal le nge 
N SAFb
N SA F F old  
C hange c
Β -lac to globul in 24 0.04 603 1 2h 5 1 0.04388 1 .0
1 8h 2 9 0.03163 0 .7
2 4h 3 9 0.02829 0 .6
4 8h 4 1 0.02922 0 .6
α- l actalbumin 7 0.01 716 1 2h 1 8 0.01901 1 .1
1 8h 1 0 0.01401 0 .8
2 4h 1 4 0.01311 0 .8
4 8h 1 4 0.01206 0 .7
α-S1-casein 8 0.01 041 1 2h 1 7 0.01181 1 .1
1 8h 2 0 0.01846 1 .8
2 4h 2 3 0.01392 1 .3
4 8h 2 2 0.01309 1 .3
α-S2-casein 6 0.00 908 1 2h 7 0.00491 0 .5
1 8h 9 0.00795 0 .9
2 4h 1 0 0.00569 0 .6
4 8h 9 0.00541 0 .6
β-ca se in 3 0.00 300 1 2h 6 0.00436 1 .5
1 8h 4 0.00325 1 .1
2 4h 6 0.00354 1 .2
4 8h 7 0.00379 1 .3
κ -  cas ei n 7 0.00 995 1 2h 9 0.00746 0 .8
1 8h 1 0 0.01076 1 .1
2 4h 1 4 0 .0092 0 .9
4 8h 1 3 0.00884 0 .9  




Relative quantification of the abundance of APP in milk during the course of 
clinical mastitis revealed increases in SAA, Hp, and the novel acute phase protein 
ITIH4.  SAA was initially detected in milk 24 hours following inoculation, and levels 
continued to increase for the duration of the study (Fig. 6A). Increases in milk Hp 
were first detected 18 h after infection with E. coli, with peak abundance evident at 
24 h that remained elevated through the 48 hr time point. The novel acute phase 




and peak expression at 18 h. In contrast to levels of SAA and Hp, the expression of 
ITIH4 in milk returned to near baseline levels by 48 h after infection.  The presence 
of A1AG was likewise detected in milk (Table 1), but expression was transient and 
thus no meaningful quantification could be performed.  
Proteins possessing antimicrobial activity were also evaluated for changes in 
relative abundance using NSAF. The most abundant antimicrobial proteins (AMP) in 
bovine milk during the course of clinical mastitis were PGRP and several members of 
the cathelicidin family of cationic AMP including cathelicidin-1, 2, and 4 (Fig. 6B).  
Peak abundance of PGRP was apparent in milk at 18 h following experimental 
induction of mastitis.  Cathelicidin-1 and -2 both began to increase in abundance in 
milk at 18 h after infusion, while Cathelicidin-4 exhibited a slightly altered 
expression pattern with increases not apparent until 24 h following infection. 
Expression of all of AMP continued to increase throughout the duration of the study 
and did not return to baseline. Similarly, MSCC (log transformed) exhibited 
significant increases (P<0.05) at 24 h following induction of clinical mastitis and 












Table 5 Normalized spectral abundance factors for vascular-derived proteins before and after 
challenge. 













Serum albumin 9 0.00485 12h 21 0.00520 1.1
18h 29 0.00923 1.9
24h 54 0.01144 2.4
48h 39 0.00823 1.7
Transferrin 0 0.00000 12h 8 0.00114 -
18h 9 0.00247 2.2
24h 12 0.00225 2.0
48h 9 0.00171 1.5
Apolipoprotein A1 0 0.00000 12h 5 0.00267 -
18h 8 0.00613 2.3
24h 13 0.00538 2.0
48h 9 0.00423 1.6
Complement C3 0 0.00000 12h 9 0.00074 -
18h 11 0.00125 1.7
24h 10 0.00066 0.9
48h 8 0.00065 0.9
Apolipoprotein A2 0 0.00000 12h 2 0.00077 -
18h 2 0.00252 3.3
24h 2 0.00194 2.5
48h 1 0.00032 0.4
Complement factor B 0 0.00000 12h 2 0.00008 -
18h 2 0.00026 3.2
24h 3 0.00023 2.9
48h 2 0.00019 2.4
Fibrinogen alpha chain 0 0.00000 12h 0 0.00000 -
18h 9 0.00138 -
24h 8 0.00144 1.1
48h 4 0.00027 0.2
Fibrinogen beta chain 0 0.00000 12h 3 0.00020 -
18h 4 0.00102 5.1
24h 6 0.00097 4.8
48h 3 0.00051 2.6
Fibrinogen gamma chain 0 0.00000 12h 0 0.00000 -
18h 3 0.00063 -
24h 3 0.00069 1.1
48h 2 0.00029 0.5  
a Average across all 8 cows; b Normalized spectral abundance factors; c Relative to pre-challenge levels 







Table 6 Normalized spectral abundance factors for proteins related to host response before 
and after challenge. 












Glycam-1 (Lactophorin) 5 0.01044 12h 10 0.00976 0.9
18h 7 0.00732 0.7
24h 7 0.00624 0.6
48h 7 0.00586 0.6
Lactoferrin 8 0.00344 12h 17 0.00360 1.1
18h 15 0.00423 1.2
24h 27 0.00489 1.4
48h 34 0.00613 1.8
Peptidoglycan recognition receptor protein 0 0.00000 12h 0 0.00000 -
18h 6 0.00324 -
24h 6 0.00281 0.9
48h 5 0.00303 0.9
Cluster in 0 0.00000 12h 3 0.00057 -
18h 3 0.00064 1.1
24h 4 0.00041 0.7
48h 1 0.00040 0.7
Cathelic idin-1 0 0.00000 12h 0 0.00000 -
18h 2 0.00072 -
24h 5 0.00303 4.2
48h 5 0.00361 5.0
Serum amyloid A 0 0.00000 12h 0 0.00000 -
18h 0 0.00000 -
24h 1 0.00050 -
48h 2 0.00148 3.0
Kininogen 2 0 0.00000 12h 3 0.00019 -
18h 3 0.00068 3.6
24h 2 0.00029 1.5
48h 0 0.00000 -
Inter-a lpha trypsin inhibi tor heavy chain 4 0 0.00000 12h 3 0.00010 -
18h 2 0.00028 2.8
24h 2 0.00014 1.4
48h 1 0.00007 0.7
Cathelic idin-2 0 0.00000 12h 0 0.00000 -
18h 1 0.00080 -
24h 2 0.00083 1.0
48h 2 0.00100 1.3
Haptoglobin 0 0.00000 12h 0 0.00000 -
18h 1 0.00021 -
24h 3 0.00044 0.2
48h 2 0.00044 0.2
Cathelic idin 4 0 0.00000 12h 0 0.00000 -
18h 0 0.00000 -
24h 3 0.00112 -
48h 4 0.00245 2.2
a Average across all 8 cows; b Normalized spectral abundance factors; c Relative to pre-challenge levels 
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Figure 6 Normalized spectral abundance factors of low abundance acute phase (A) and antimicrobial 
proteins (B). * denotes significant changes (P<0.05) relative to time zero. 
 
Temporal expression of novel markers of coliform mastitis 
The abundance and temporal expression patterns of novel biomarkers of coliform 
mastitis detected in bovine milk during the course of an experimentally induced 
clinical infection were evaluated using NSAF.  Comparisons made included ITIH4 
and kininogen-2 (Fig. 7A), relative abundance of apolipoprotein A-I and A-II and the 
adhesion molecule Glycam-1 (Fig. 7B), and the expression patterns of apolipoprotein 
A-I and the relatively uncharacterized protein apolipoprotein J, or clusterin (Fig. 7C).   
Despite the low relative abundance of the novel biomarkers of host response, 
similarities in the expression patterns of the host response proteins were detected. 
Temporal expression of the kallikrein-sensitive acute phase protein ITIH4 and the 




apparent by 12 h following infection and peak expression at 18 h. Similarly, levels of 
ITIH4 and kininogen-2 returned to baseline by 48 h following inoculation. Both 
kininogen-1 and kininogen-2 were identified in mastitis milk in the current analyses, 
but kininogen-2 was found in higher abundance.  Because the two kallikrein proteins 
have nearly homologous sequences, an alignment was performed using the alignment 
tool ClustalW, and differences in the amino acids sequences investigated.  Two 
peptides that mapped to single amino acid differences between kininogen-1 and 
kininogen-2 were assigned to kininogen-2, which verified the presence of both 
isoforms of the bradykinin precursor in the mastitic milk samples (Fig. 8). 
 
Figure 7 Evaluation of potential protein interactions over the course of experimental infection using 
NSAF.  
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Figure 8 Portion of sequence alignment of kininogen 1 and 2. The two differentiable peptides assigned 
to kininogen-2 are flanked by arrows; single amino acid differences are marked with a “:” and “.” for 
each peptide, respectively. Amino acids that are in accord for both protein sequences are marked by a 
“*”. 
  
 Levels of apolipoprotein A-I and A-II peaked at 18 h during infection which 
corresponded to maximal decreases in the adhesion molecule Glycam-1.  Abundance 
of apolipoprotein A-II returned to baseline by 48 h following infection, but levels of 
apolipoprotein A-I and Glycam-1 were still elevated at the conclusion of the analyses.  
Comparison of apolipoprotein A-I and clusterin revealed patterns of temporal 
expression that were similar despite the apparent lower abundance of clusterin.  
Discussion 
Whey from bovine milk samples collected prior to infection with E. coli (0 h), and 
at 12, 18, 24, and 48 following infection with E. coli were digested in-solution with 
trypsin, separated using nano-reverse phase liquid chromatography (nano-RP-LC), 
and identified by peptide sequencing using data dependent nano-spray tandem mass 
spectrometry followed by database searching.  No sample depletion or removal of 
high abundance proteins was performed prior to analysis and only a one-dimensional 
LC separation was employed.  In accord with previous proteomic analyses that did 
not involve sample clean-up, the abundant milk proteins BSA, β-lactoglobulin, α-
lactalbumin, α-S1-casein, β-casein, and κ-casein were identified in the whey samples 
sp|P01044|KNG1_BOVIN      SSFSQKCDLYPVKDFVQPPTRLCAGCPKPIPVDSPDLEEPLSHSIAKLNAEHDGAFYFKI 300 
sp|P01045|KNG2_BOVIN      SSFSQKCDLYPGEDFLPP--MVCVGCPKPIPVDSPDLEEALNHSIAKLNAEHDGTFYFKI 298 
                          *********** :**: *   :*.***************.*.************:***** 
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of all 8 cows collected at each time point (Smolenski et al., 2007). Additionally, the 
proteins lactoferrin and Glycam-1 were identified in milk from all cows included in 
the study, and at all the time points analyzed (Table 1). 
A total of 275 proteins were identified, but stringent criteria were applied to the 
selection of proteins to be considered for evaluation of temporal expression including: 
identification in milk samples from more than one cow, identity based on more than 
one peptide, and peptide assignments identified with Ion Scores greater than Identity 
(McFarland et al., 2008). Proteins identified by a single peptide did not meet 
inclusion criteria and were culled. Though a large number of proteins were discarded, 
a total of 68 proteins were successfully identified in more than one cow at two or 
more time points following infection.  The results of the current study represent the 
first longitudinal analyses of milk samples over the course of a clinical infection to 
yield robust identification of biologically relevant proteins related to host response, 
including nearly 20 proteins not previously identified in whey from mastitic milk 
using proteomic strategies (Hogarthe et al., 2004: Smolenski et al., 2007).  
Proteins related to host response identified in bovine milk included: the plasma-
derived proteins BSA, transferrin, fibrinogen α, β, and γ chains, apolipoprotein A-I 
and A-II, A-IV, and C-3, and complement factor C3 and B, as well as several cationic 
AMP, osteopontin, bradykinin precursors, cell adhesion proteins, and the APP SAA, 
Hp, ITIH4, and A1AG (Table 3). While some of the protein identifications were in 
accord with previous proteomic analyses of mastitic milk fractions, (Hogarth et al., 
2004; Smolenski et al., 2007), several host response-related proteins that were 




milk proteome including: SAA, Hp, apolipoprotein A-I, A-II, C3, and E, complement 
factor B, osteopontin, cathelicidin-2, -3, -5, -6, -7, and prothrombin (Table 2). 
Additionally, novel markers of bovine mastitis were detected including ITIH4, a 
novel APP (Pineiro et al., 2004) and kininogen-2, a precursor to the eicosanoid 
bradykinin (Sharfstein et al., 2007). 
Label- free quantification of two high abundance proteins, BSA and β-
lactoglobulin, and two low abundance proteins, complement factor B and 
osteopontin,  was performed using NSAF as previously described (Florens et al., 
2006; Zybailov et al., 2006; Mosley et al., 2008).  Additionally, normalized number 
of unique peptides identified was used to evaluate the relative abundance of the same 
proteins.  For low abundance proteins, the difference in temporal expression patterns 
determined using NSAF versus number of unique peptides was negligible (Fig. 1C, 
1D).  The most plausible explanation is that due to the overabundance of a select 
number of proteins in milk, only a limited number of peptides were identified for 
proteins related to host response, and the MS/MS sampling rates of low abundance 
peptides were equivalent to the number of peptide assignments. Greater differences 
existed between the number of peptides identified and the number of times each 
precursor peptide triggered an MS/MS event for the more abundant proteins, 
however, particularly at the early time points following infection (Fig. 1A, 1B). 
Proteins related to host response were absent or in very low abundance at 0h and 12 
h, thus the composition of the milk was primarily characterized by high abundance 
whey and casein proteins.  The large differences between number of peptides 




abundant proteins, including BSA and β-lactoglobulin, yielded tryptic peptides with 
MS/MS sampling rates that exceeded the peptide assignments for each protein 
(Mueller et al., 2008). Normalization of number of unique peptides assigned to 
abundant proteins at earlier time points in the analyses resulted in estimates that were 
skewed towards the abundant proteins, and elevated relative to other proteins present 
in the milk.  Thus, using number of unique peptides as a measure of relative 
abundance was not an accurate means of modeling temporal expression of abundant 
milk proteins over the entire time course of clinical infection in the current protein 
data set.    
Spectral counts proved to be more sensitive measures of protein abundance, 
however, and thus NSAF were more accurate for semiquantitiative analysis of milk 
protein modulation during clinical mastitis for the protein data set generated using 
nano-LC coupled to a nano-spray ionization ion-trap mass spectrometer.  
Explanations include the fact that NSAF account for the higher MS/MS sampling 
rates of peptides assigned to abundant proteins. NSAF also reflect the size of the 
protein, and, indirectly the number of potential tryptic peptides the protein can 
theoretically yield (Florens et al., 2006; Zybailov et al., 2006; Mosley et al., 2008).  
The disparity between measures of relative abundance based on spectral counts and 
number of peptides supported the hypothesis that the dynamic range of proteins 
present in a given biological matrix will effect the accuracy of label-free 
quantification, and that spectral counts are better suited for the analysis of moderate 
mass resolution LC-MS/MS data generated on an ion-trap instrument (Mueller et al., 




counts and number of unique peptides supported previous reports that spectral count 
data is more accurate when applied to the semiquantitiative analysis of medium to 
high abundance proteins (Mueller et al., 2008).   
Label- free quantification remains a topic of debate in terms of suitability for 
measuring changes in the relative changes of low abundance proteins (Mosley et al., 
2008; Mueller et al., 2008).  To date, there is no universal agreement on the most 
appropriate means to evaluate changes in relative abundance of proteins that are 
transient in expression, or that are not present in all samples included in a longitudinal 
study. Likewise, when dealing with the comparison of complex biological matrices in 
healthy versus diseased states, the challenge remains to accurately quantify changes 
in proteins that are only present in the diseased state, and to differentiate between 
changes in relative abundance that are biologically relevant versus statistically 
significant. Used as a screening tool to identify biomarkers that exhibit differential 
expression, however, label-free quantification based on NSAF could prove useful as a 
filter for distinguishing biomarkers that merit more rigorous follow-up validation 
studies and absolute quantification. 
Extracted ion chromatograms (XIC) have been used to quantify proteins in 
complex mixtures by utilizing the mean peak area, or the sum of total ion intensity, of 
all peptides identified for each protein in a sample as a measure of abundance (Old et 
al., 2005; Bondarenko et al., 2002) To compare trends in temporal expression 
determined using the two different label-free methods, NSAF and XIC for the 
proteins BSA (Fig. 2A) and Hp (Fig. 2B) were evaluated. Changes in relative 




protein BSA and the low abundance protein haptoglobin.  Using both methods of 
label-free semiquantitative analysis, peak abundances of both BSA and Hp were 
detected at 24 h following infection with E. coli, which was in agreement with 
previously published results for both proteins (Bannerman et al., 2008; Suojala et al., 
2008), and with abundance determined using NSAF. Normalized spectral abundance 
factors appeared to accurately model changes in relative abundance of the proteins 
detected in milk both before and after infection with E. coli and thus NSAF were used 
throughout the remainder of the analyses to evaluate changes in the temporal 
expression of differentially expressed bovine milk proteins during coliform mastitis. 
In the previous analyses, normalized number of unique peptides was compared to 
ELISA data generated on the proteins BSA, lactoferrin, and transferrin to evaluate the 
similarity of trends detected in the modulation of relative protein abundance across 
various times following infection using label free quantification and an antibody-
based methodology.  In the protein data set generated using HPLC coupled to the Q-
TOF mass spectrometer, however, lactoferrin and transferrin represented low 
abundance proteins as fewer peptides were detected for each protein than in the 
current protein data set. To evaluate the accuracy of NSAF in detecting changes in 
relative abundance of high and low abundance proteins using nano-LC in-line with 
nano-spray-MS/MS, comparisons were made to ELISA data for BSA, Hp, and SAA.  
As in the previous analyses, temporal expression patterns determined using 
ELISA and NSAF were in accord for both high and low abundance proteins. ELISA 
measurements of the concentration of BSA (Fig. 3A) across the time points before 




(Bannerman et al., 2004; 2008). Increased concentrations of milk BSA is a well 
established hallmark of coliform mastitis known to result from increased vascular 
permeability following the induction and action of pro-inflammatory cytokines 
following pathogen invasion (reviewed in Bannerman 2009). Additionally, there is 
evidence for the local production of serum albumin in the bovine mammary gland 
following exposure to LPS (Shamay et al., 2005). Similar to BSA, results of ELISA 
measurements of Hp (Fig. 3B) and SAA (Fig. 3C) concentrations following 
experimental induction of coliform mastitis were also in accord with previous 
analyses of milk APP levels in milk during clinical mastitis (Eckersall et al., 2001; 
Hiss et al., 2004; Grönlund et al., 2005).  The present study does, however, mark the 
first instance of the identification of APP in the whey fraction of milk from cows with 
experimentally-induced clinical mastitis using proteomics.  The comparison of 
semiquantitative measures to concentrations of proteins in milk during coliform 
mastitis determined using ELISAs is an additional novel aspect of the current 
analyses.  The identification of APP using proteomics and the outcome of the 
comparison of quantitative measures indicate the applicability of LC-MS/MS in the 
analysis of complex biological matrices and the identification of low abundance 
proteins, and the feasibility of using NSAF to model protein modulation in bovine 
milk during disease. 
Temporal expression of abundant whey and casein proteins using NSAF yielded 
results that were in accord with the previous analyses carried out using HPLC in line 
with a Q-TOF mass spectrometer.  Peak increases in milk BSA were detected at 24 h 




β-lactoglobulin and α-lactalbumin (Fig. 4A). No significant fold-changes were 
detected in either β-lactoglobulin or α-lactalbumin, but 2-fold changes in abundance, 
as determined by the comparison of pre-challenge NSAF to abundance factors at later 
time points, were apparent in BSA at 18 h and 24 h following infection, which was in 
accord with significant differences (P<0.05) determined using an ELISA. Apparent 
decreases in the whey proteins β-lactoglobulin and α-lactalbumin agreed with 
previous reports of reduced expression during clinical mastitis (Hogarth et al., 2004), 
but in the prior proteomic analysis, temporal expression was not evaluated. In accord 
with previous proteomic analyses of the temporal expression of abundant casein 
proteins before and during clinical mastitis, no significant fold-changes were detected 
in casein expression across the time course analyzed (Fig. 4B). A reduction in αS1-
casein mRNA levels has been reported following experimental induction of coliform 
mastitis using E. coli, but no significant decreases in protein synthesis were detected, 
which supports the results of the current study (Vanselow et al., 2006). 
Previous E. coli challenge studies have characterized cytokine expression 
during coliform mastitis (reviewed in Bannerman, 2009). Classic hallmarks of 
coliform mastitis following cytokine induction include fever, complement activation, 
hepatic production of APP (Dinarello, 1996; Grönlund et al., 2005; Suojala et al., 
2008), and the leakage of plasma proteins and complement factors into the milk 
(Shuster et al., 1997; Riollet et al., 2000; Bannerman et al., 2004; 2008).  The 
cytokines IL-1β and TNFα are known to induce pyrexia and vascular leak during 
coliform mastitis, and peak expression of both cytokines has been reported between 




accord with previously published reports on cytokine expression and the secondary 
effects of cytokine induction, vascular derived proteins were detected in bovine milk 
following experimental induction of coliform mastitis (Table 5). Peak expression of 
plasma proteins including complement factors C3 and B (Fig. 5A), fibrinogen –α, -β, 
and –γ chains (Fig. 5B), and the apolipoproteins A-I and A-II (Fig. 5C) was apparent 
between 18 h and 24 h after infusion, which corresponded to established cytokine 
expression patterns. 
Another hallmark of intramammary infection is the rapid influx of 
polymorphonuclear neutrophils (PMN) into the gland following pathogen invasion. 
PMN are known to be the primary component of milk somatic cell counts (MSCC) 
during intramammary infection (Paape et al., 1981), and are also a well established 
source of AMP including PGRP, and members of the cathelicidin family of cationic 
AMP (Scocchi et al., 1997; Tomasinsig and Zanetti, 2005; Tydell et al., 2006). 
Increases in MSCC (log transformed) were evident 12 h following experimental 
induction of coliform mastitis, with peak increases in milk somatic cells at 24 h after 
infusion that remained elevated for the duration of the study (Fig. 6C). Elevation of 
MSCC in the current analysis modeled patterns detected in previous challenge studies 
(Bannerman et al., 2008). Corresponding to peak influx of PMN were increases in 
several AMP including cathelicidin-1, -2, and-4, as well as PGRP (Fig. 6B). Both the 
cathelicidins and PGRP are known to be involved in innate immunity, and to exhibit 
antibacterial activity in cattle (Tydell et al., 2006; Dziarski, 2003). The cathelicidins 
in particular inactivate and destroy invading pathogens by perturbing microbial 




cathelicidins might function in endotoxin neutralization, as well as down-regulation 
of cytokine expression (Scott et al., 2002; Wiese et al., 2003; Zanetti et al., 2004). 
Both PGRP and cathelicidin-1 were identified in the 2D-GE MALDI-TOF-MS 
analyses of whey from mastitic bovine milk, but the current proteomic analysis marks 
the first robust evaluation of the temporal expression of AMP during coliform 
mastitis. While AMP represented a low abundance component of the milk samples 
analyzed, the temporal expression patterns determined using NSAF were based on a 
greater number of peptide assignments than in earlier evaluations, and exhibited  a 
better fit to clinical data.  
The temporal expression of a select number of proteins related to host response 
identified in the mastitic milk samples were examined in further depth because the 
markers were novel, or there were previous reports of related expression. A protein of 
particular interest was the novel APP ITIH4.  Prior reports of ITIH4 in cattle are 
limited to isolation of the positive APP from the serum of heifers with experimentally 
induced summer mastitis (Pineiro et al., 2004).  ITIH4 has never been identified in 
bovine milk, and has never been associated with coliform mastitis in lactating dairy 
cattle.   ITIH4 has, however, been studied in models of acute inflammation in the pig 
(Gonzalez-Ramon et al., 2000), and was recently reported to be a novel marker of 
acute ischemic stroke in humans (Kashyap et al., 2009).  Previous research and 
similarity to a human homolog led to the classification of ITIH4 as a plasma 
kallikrein-sensitive glycoprotein, but the exact role and function of ITIH4 in the 
bovine mammary gland during inflammation associated with coliform mastitis is not 




known to play keys roles in blood coagulation (Furie and Furie, 1988), fibrinolysis 
(Ichinose et al., 1984), activation of complement (Discipio, 1982), and the release of 
bradykinin from its precursor, kininogen (Sharfstein et al., 2007).  Recently, both 
macrophages and neutrophils were demonstrated to possess binding sites for the 
kininogens (Barbasz et al., 2008; Kahn et al., 2009), and thus MSCC, which were 
elevated in milk at nearly the same time kininogen increases were detected, could 
represent a potential source of the bradykinin precursors.  
The kinin peptides, including bradykinin, are potent mediators of vasodilation, 
pain, and udder edema during clinical mastitis (Eshraghi et al., 1999). The 
relationship between elevated levels of milk bradykinin and increased severity of 
clinical symptoms of mastitis has been demonstrated, but bradykinin levels in milk 
from cows with experimentally induced coliform mastitis have not yet been 
investigated (Eshraghi et al., 1999).  Kininogen-1 has been identified in prior 
proteomic analyses of normal bovine milk (Fong et al., 2008), and the presence of 
bradykinin in normal milk has likewise been previously reported (Leach et al., 1967), 
but there are no previous reports of kininogen-2 discovery in bovine milk. 
Furthermore, while the activation of complement and the cleavage of complement 
proteins into active peptides that further enhance the inflammatory response have 
been documented during coliform mastitis (Shuster et al., 1997; Riollet et al., 2000; 
Bannerman et al., 2004), less is known about the contributions of the kallikrein-kinin 
system to inflammation in the bovine mammary gland. Previous studies of 




serves as a potent inducer of dendritic cell (DC) maturation, and could be a potential 
link between innate and adaptive immune responses (Aliberti et al., 2003).  
Both kininogen-1 and -2 were identified in the current analyses, but kininogen-2 
was identified in a greater number of cows, and had more peptide assignments on 
average across the time points sampled than kininogen-1 (Table 1). Though 
kininogen-1 and -2 are highly conserved and share a great deal of sequence 
homology, alignment of  the protein sequences confirmed single amino acid 
differences that mapped to 2 distinct peptides assigned to kininogen-2, which 
confirmed the identification of both isoforms in the milk samples (Fig. 8). However, 
whether the kininogen isoforms possess distinct physiological roles during 
inflammation associated with coliform mastitis cannot be inferred from the results of 
the current study. 
Temporal expression of ITIH4 and kiningen-2 revealed nearly identical patterns 
across the course of mastitis with peak increases in both proteins evident at 18 h 
following infection with E. coli (Fig. 7A). Changes in relative abundance were 
greater than 2-fold for both ITIH4 and kiningen-2, but the relevance of the fold 
increases should be regarded as biologically relevant as opposed to statistically 
significant, because a limited number of peptides were identified for each of the 
proteins (Mueller et al., 2008). Both ITIH4 and kininogen-2 were, however, detected 
in nearly all of the time points following infection, and relative to other low 
abundance proteins identified, had a greater number of peptide assignments at each 
sampling. Likewise, maximal increases in both ITIH4 and kininogen-2 were in accord 




induced coliform mastitis (reviewed in Bannerman 2009).  Though the calculated 
abundance factors are tentative due to the limited number of identified peptides, 
kininogen-2 and ITIH4 are clearly linked to host response following infection in the 
bovine mammary gland, and merit further investigation as potential biologically 
relevant biomarkers of coliform mastitis. 
Proteins that were consistently identified in higher abundance across all analyses 
conducted following infection with E. coli were the apolipoproteins.  In all, 5 separate 
isoforms of apolipoprotein were identified in the current analysis, though 
apolipoprotein A-I and apolipoprotein A-II were the most abundant. Apolipoproteins 
are typically associated with high density lipoproteins (HDL), but other roles for the 
apolipoproteins during disease, and inflammation in particular, have been 
investigated (Bausserman et al., 1988; Cockerill et al., 2000; Burger and Dayer, 
2002).  The relationship between SAA and apolipoprotein A-I was investigated 
following induction of the acute phase response in human subjects (Bausserman et al., 
1988). SAA, like the apolipoproteins, is transported in association with HDL.  
Increases in apolipoprotein A-I in particular have been associated with chronic 
inflammatory diseases such as rheumatoid arthritis, but at an undefined threshold 
SAA displaces apolipoprotein A-I from HDL and as a result, peak increases in SAA 
lead to a decline in the apoliproteins (Bausserman eta l., 1988; Burger and Dayer, 
2002). Though the temporal expression patterns of the apolipoproteins and SAA were 
not specifically investigated in these analyses, examination of the changes in relative 
abundance of SAA (Fig. 3C) and apoliopoprotein A-I and A-II (Fig. 6C) indicate that 




decline, which is in accord with previous reports (Bausserman et al., 1988; Burger 
and Dayer, 2002). 
A relationship that was specifically investigated was the potential reduction in 
adhesion molecules associated with leukocyte recruitment due to increases in 
abundance of apolipoproteins.  Previous research has indicated that HDL, of which 
apolipoproteins are a major constituent, inhibit the cytokine-induced upregulation of 
E-selectin, vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion 
molecule-1 (ICAM-1) in vitro as well as in vivo (Cockerill et al., 2000).  Glycam-1 is 
a lymphocyte trafficking protein produced in the bovine mammary gland as well as in 
high endothelial venules (HEV) in lymph nodes (Nishimura, 2003). Glycam-1 is 
expressed by endothelial cells in the lactating mammary gland and secreted into milk, 
but the glycosylation state of the mammary form of Glycam-1 is different from the 
form of Glycam-1 detected in lymph nodes, and the mammary form of the protein is 
not thought to be involved in lymphocyte trafficking (Nishimura, 2003).  The actual 
function of glycam-1 in the mammary gland thus remains undefined. 
Glycam-1 was one of the only proteins detected in milk samples collected from 
all 8 cows included in the study both before and at all the time points following 
infection with E. coli. To investigate potential a relationship between the Glycam-1 
protein detected in milk and the apolipoproteins A-I and A-II, temporal expression of 
all 3 proteins was examined graphically (Fig. 7B). The relationship was not profound, 
but increases in apolipoproteins A-I and A-II did appear to coincide with decreases in 
milk glycam-1.  However, the glycosylation state of the glycam-1 protein present in 




current analyses whether or not the apolipoproteins had any down-regulatory effects 
on the expression of glycam-1 in bovine milk during coliform mastitis, or whether the 
form of glycam-1 detected in the milk was involved in lymphocyte trafficking. 
 Clusterin is another poorly characterized protein identified only in milk 
samples following experimental induction of coliform mastitis.  In previous research, 
clusterin has also been referred to as apolipoprotein J, and has been shown to bind 
apolipoprotein A-I (McLaughlin et al., 2000; Jones and Jomary, 2002; Rosenburg et 
al., 2002). While the absolute function of clusterin remains unclear, the involvement 
of clusterin in several inflammatory diseases including myocarditis, and 
glomerulopathy has been implicated from previous research (McLaughlin et al., 2000; 
Rosenburg et al., 2002). Results of prior research likewise indicate that clusterin 
could possess anti-inflammatory properties (McLaughlin et al., 2000; Rosenburg et 
al., 2002).   In terms of the role of clusterin in the bovine mammary gland, all that has 
been inferred is that clusterin could be associated with mammary gland involution, 
the clearance of cellular debris, and apoptotic cell death (Jones and Jomary, 2002). 
Because of the prior association with apolipoproteins and apolipoprotein A-I in 
particular, the temporal expression pattern of clusterin was compared to that of 
apolipoprotein A-I (Fig. 7C). Though no actual direct associations could be inferred 
from the graphic representation, comparison of changes in relative abundance of the 
two proteins revealed nearly identical patterns, though clusterin was in lower 
abundance than apolipoprotein A-I.  A possible role for clusterin during inflammation 
associated with coliform mastitis cannot be deduced from the outcome of the current 




clusterin could merit further investigation as a potential biomarker of coliform 
mastitis. 
Clearly, several challenges still remain regarding the identification and accurate 
quantification of biomarkers of host response in bovine milk following experimental 
induction of coliform mastitis. Nonetheless, the results of the current proteomic 
analysis provide information that could prove useful in the design and execution of 
future studies of inflammatory biomarkers in bovine milk.  Contributions of the 
present study include the robust identification of several biologically relevant proteins 
related to host response in the bovine mammary gland including APP, AMP, 
vascular-derived proteins, bradykinin precursors, and cell adhesion factors. 
Additionally, an evaluation of semiquantitative methods for assessing changes in 
relative abundance of milk proteins during coliform mastitis evidenced that despite 
inherent flaws and the current lack of supporting statistical analysis, NSAF appear to 
effectively model protein modulation during clinical infections.  Likewise, the 
number of proteins identified using nano-LC in line with nano-spray MS/MS 
indicated the suitability of the instrument system for identifying low abundance 
proteins in bovine milk, despite the biological complexity of the samples, and the 
profound variation in protein dynamic range across time points following challenge. 
Finally, the results of the current study represent the first longitudinal analysis of 
bovine milk samples over the course of a controlled clinical infection to include 
quantitative assessments of protein modulation, and to provide robust identification of 
several biomarkers of host response, including novel and potentially diagnostically 




Chapter 7:  Conclusions 
Proteomic analysis of bovine milk and attempts to identify biomarkers of 
inflammation which were indicative of coliform mastitis posed several challenges.  
Specific hindrances included the lack of established methods for the robust 
identification of proteins in milk using proteomic methodologies, and the inherent 
difficulties associated with analyzing milk, which is a very complex biological 
matrix. Additionally, quantification of protein modulation over the course of clinical 
mastitis posed numerous additional obstacles due primarily to the extreme dynamic 
range of proteins present in bovine milk, but also due to profound fluctuations in 
protein content during infection.  Nonetheless, the outcomes of the analyses 
conducted have afforded several insights into the dynamics of milk protein expression 
during disease, and have established useful parameters and methods for future 
analyses.  Based on the propounded research, the following deductions can me made: 
1. Proteomics is a viable and accurate means of identifying and assessing 
milk protein expression in bovine milk during an altered physiological 
state. 
2. Detection of cytokines involved in the innate immune response during 
coliform mastitis is most accurately assessed using available antibody-
based methodologies, including ELISAs, and could not be accomplished 
using 2D-GE followed by MALDI-TOF-MS, or LC-MS/MS using the 
methods employed in the current series of analyses, regardless of 




clinical mastitis using proteomics could enhance current knowledge of the 
effects and actions of cytokines during innate immunity, elucidate 
pathways or mechanisms of host response not previously known, and 
serve as valuable and diagnostically relevant biomarkers of coliform 
mastitis. 
3. Proteins related to host response that are most amenable to identification 
using proteomics include vascular-derived proteins, acute phase proteins, 
antimicrobials proteins, and a select number of cell adhesion factors.  
Despite the presence of several highly abundant proteins, and the fact that 
no sample clean-up or fractionation strategies were applied, several low 
abundance proteins, including some proteins not previously identified in 
milk, were identified using 2D-GE followed by MALDI-TOF-MS, and by 
LC-MS/MS. 
4. Despite inherent deficiencies in label-free semiquantitative analyses, 
evidence based on comparisons to ELISA data and an accepted and widely 
used means of label-free quantification demonstrated that NSAF is a 
potentially valuable screening tool for the assessment of changes in 
relative abundance of novel biomarkers.  
5. Applying proteomic methodologies to the analysis of bovine milk 
following experimental induction of coliform mastitis resulted in the 
identification of potentially novel biomarkers of coliform mastitis not 




the acute phase protein ITIH4; 2) two isoforms of kininogen, the 
precursors to bradykinin; and 3) the relatively uncharacterized protein, 
clusterin. 
In conclusion, the results of the current series of proteomic analyses of bovine 
milk have enhanced current knowledge of the bovine milk proteome, established 
more accurate methods for identifying milk proteins, and provided information on 
previously uncharacterized biomarkers in bovine milk during coliform mastitis 









Supplemental Figure 1. 2D-GE on a 0 h (A), 12 h (B), 18 h (C), 24 h (D), and 36 h 
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KCMF1_BOVIN Q1LZE1 E3 ubiquitin-protein ligase KCMF1 2 1 1 12 h
A2MG_BOVIN Q7SIH1 Alpha-2-macroglobulin 3 1 1 18 h
LONM_BOVIN Q59HJ6 Lon protease homolog, mitochondrial 3 1 1 18 h
PLCB4_BOVIN Q07722 1-phosphatidyinositol-4,5-biphosphate phosphodiesterase beta-4 3 1 1 18 h
EF1G_BOVIN Q3SZV3 Elongation factor 1-gamma 2 1 1 18 h
SNX17_BOVIN Q5EA77 Sorting nexin-17 2 1 1 18 h
ANG1_BOVIN P10152 Angiogenin-1 3 1 1 24 h
HBA_BOVIN P01966 Hemoglobin subunit alpha 2 1 1 24 h
LIPL_BOVIN P11151 Lipoprotein lipase 2 1 1 24 h
SBP1_BOVIN Q2KJ32 Selenium binding protein 1 2 1 1 24 h
PLMN_BOVIN P06868 Plasminogen 3 1 1 24 h
OMA1_BOVIN Q3SZN3 Metalloendopeptidase OMA1 2 1 1 24 h
KGUA_BOVIN P46195 Guanylate kinase 2 1 1 24 h
PROF1_BOVIN P02584 Profilin-1 5 3 2 48 h
CD36_BOVIN P26201 Platelet glycoprotein 4 2 1 1 48 h
TPST2_BOVIN Q3SYY2 Protein-tyrosine sulfotransferase 2 2 1 1 48 h
LBP_BOVIN Q2TBI0 Lipopolysaccharide-binding protein 2 1 1 48 h
DFB11_BOVIN P46169 Beta-defensin 11 2 1 1 48 h
FOLR1_BOVIN P02702 Folate receptor alpha 2 1 1 48 h







2D-GE  Two-dimensional gel electrophoresis 
A1AG  Alpha-1 acid glycoprotein 
AMP  Antimicrobial peptides 
APP  Acute phase protein 
BAMP-1 Bovine antimicrobial protein-1 
BSA   Bovine serum albumin 
CD-14  Cluster of differentiation -14 
CFU  Colony-forming units 
CHCA  α-cyano-4-hydroxycinnamic acid 
CID  Collision-induced dissociation 
COX  Cyclooxygenase 
CVM  Center for Veterinary Medicine 
DC  Dendritic cell 
DHB  2,5-dihydroxybenzoic acid 
DIM  Days in milk 
DTT  Dithiothreitol 
ELISA  Enzyme-linked immunosorbent assay 
ESI  Electrospray ionization 
FABP  Fatty acid binding protein 
FDA  Food and Drug Administration 




GIST  Global internal standard 
Glycam-1 Glycosylation-dependent cell adhesion molecule-1 
HDL  High density lipoprotein 
HEV  High endothelial venules 
Hp  Haptoglobin 
HPLC  High pressure liquid chromatography 
ICAM-1 Intercellular adhesion molecule-1 
ICAT  Isotope coded affinity tags 
IEF  Isoelectric point 
IFN-γ  Inteferon gamma 
IgG  Immunoglobulin-G 
IgM  Immunoglobulin-M 
ITIH4  Inter-alpha trypsin inhibitor heavy chain-4 
IL-1β  Interleukin-1 beta 
IL-6  Interleukin-6 
IL-8  Interleukin-8 
IPG  Immobilized pH gradient 
iTRAQ Isobaric tags for relative and absolute quantitation 
LBP  Lipopolysaccharide-binding protein 
LC  Liquid chromatography 
LC-MS Liquid chromatography mass spectrometry 
LC-MS/MS Liquid chromatography tandem mass spectrometry 




MALDI Matrix-assisted laser desorption/ionization 
MFGM Milk fat globular membrane 
MEC  Mammary epithelial cells 
MS  Mass spectrometry 
MSCC  Milk somatic cell counts 
MS/MS Tandem mass spectrometry 
MSCS  Milk somatic cell score 
m/z  Mass-to-charge ratio 
NFκB  Nuclear factor kappa beta 
NSAF  Normalized spectral abundance factor 
NSAID Non-steroidal anti-inflammatory drug 
ONADE Office of New Animal Drug Evaluation 
PAF  Platelet-activating factor 
PBS  Phosphate buffered saline 
PCR  Polymerase chain reaction 
PGE2  Prostaglandin E2 
PGRP  Peptidoglycan recognition receptor protein 
PIGR  Polymeric immunoglobin receptor 
PMF  Peptide mass fingerprinting 
PMN  Polymorphonuclear neutrophils 
PSD  Post source decay 
PTM  Post translational modification 




RP-LC  Reverse phase liquid chromatography 
RT-PCR Reverse transcriptase polymerase chain reaction 
SAA  Serum amyloid A 
SE  Standard error 
SILAC  Stable isotope labeling by amino acids in cell culture 
SCC  Somatic cell counts 
SPA  Sinapinic acid 
TEAB  Triethylammonium bicarbonate 
TCEP  Tris(2-carboxyethyl)phosphine 
TFA  Trifluoroacetic acid 
TGF-α  Transforming growth factor-alpha 
TGF-β  Transforming growth factor-beta 
TLR  Toll-like receptor 
TNFα  Tumor necrosis factor-alpha 
TOF  Time-of-flight 
TTR  Transthyretin 
UPLC  Ultra-pressure liquid chromatography 
VCAM-1 Vascular cell adhesion molecule-1 
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